10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________________________________________________

FORM 10-Q

________________________________________________

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number: 001-38636

________________________________________________

Garrett Motion Inc.

(Exact Name of Registrant as Specified in its Charter)

________________________________________________

Delaware	82-4873189
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
La Pièce 16, Rolle, Switzerland	1180
(Address of principal executive offices)	(Zip Code)

+41 21 695 30 00

(Registrant’s telephone number, including area code)

N/A

(Former Name, Former Address and Former Fiscal Year,

if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	GTX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐

As of October 18, 2023, the registrant had 242,419,764 shares of Common Stock, $0.001 par value per share, outstanding.

Table of Contents

		Page
PART I.	FINANCIAL INFORMATION	2
Item 1.	Financial Statements (Unaudited)	2
	Consolidated Interim Statements of Operations (Unaudited)	2
	Consolidated Interim Statements of Comprehensive Income (Unaudited)	3
	Consolidated Interim Balance Sheets (Unaudited)	4
	Consolidated Interim Statements of Cash Flows (Unaudited)	5
	Consolidated Interim Statements of Equity (Deficit) (Unaudited)	6
	Notes to Consolidated Interim Financial Statements (Unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	38
PART II.	OTHER INFORMATION	39
Item 1.	Legal Proceedings	39
Item 1A.	Risk Factors	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 3.	Defaults Upon Senior Securities	39
Item 4.	Mine Safety Disclosures	39
Item 5.	Other Information	40
Item 6.	Exhibits	41
Signatures		42

1

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

GARRETT MOTION INC.

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions, except per share amounts)
Net sales (Note 3)	$	960	$	945	$	2,941	$	2,705
Cost of goods sold	784		767		2,374		2,183
Gross profit	176		178		567		522
Selling, general and administrative expenses	59		57		178		164
Other expense, net	1		1		3		2
Interest expense	50		18		108		61
Loss on extinguishment of debt	—		—		—		5
Non-operating income	(4)		(29)		(1)		(73)
Reorganization items, net	—		—		—		2
Income before taxes	70		131		279		361
Tax expense (Note 5)	13		26		70		83
Net income	57		105		209		278
Less: preferred stock dividends (Note 15)	—		(40)		(80)		(117)
Less: preferred stock deemed dividends (Note 15)	—		—		(232)		—
Net income (loss) available for distribution	$	57	$	65	$	(103)	$	161
Earnings (loss) per common share
Basic	$	0.23	$	0.21	$	(0.73)	$	0.52
Diluted	0.23		0.21		(0.73)		0.52
Weighted average common shares outstanding
Basic	250,888,716		64,820,887		141,745,701		64,834,298
Diluted	252,381,719		65,250,287		141,745,701		65,118,021

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

2

GARRETT MOTION INC.

CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Net income	$	57	$	105	$	209	$	278
Foreign exchange translation adjustment	14		10		8		13
Changes in fair value of effective cash flow hedges, net of tax (Note 16)	(2)		9		(3)		26
Changes in fair value of net investment hedges, net of tax (Note 16)	20		45		18		87
Total other comprehensive income, net of tax	32		64		23		126
Comprehensive income	$	89	$	169	$	232	$	404

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

3

GARRETT MOTION INC.

CONSOLIDATED INTERIM BALANCE SHEETS

(Unaudited)

	September 30, 2023		December 31, 2022
	(Dollars in millions)
ASSETS
Current assets:
Cash and cash equivalents	$	162	$	246
Restricted cash	1		2
Accounts, notes and other receivables – net (Note 6)	860		803
Inventories – net (Note 8)	294		270
Other current assets	73		110
Total current assets	1,390		1,431
Investments and long-term receivables	32		30
Property, plant and equipment – net	437		470
Goodwill	193		193
Deferred income taxes	225		232
Other assets (Note 9)	255		281
Total assets	$	2,532	$	2,637
LIABILITIES
Current liabilities:
Accounts payable	$	1,066	$	1,048
Current maturities of long-term debt (Note 14)	7		7
Accrued liabilities (Note 11)	312		320
Total current liabilities	1,385		1,375
Long-term debt (Note 14)	1,622		1,148
Deferred income taxes	21		25
Other liabilities (Note 12)	196		205
Total liabilities	$	3,224	$	2,753
COMMITMENTS AND CONTINGENCIES (Note 20)
EQUITY (DEFICIT)
Series A Preferred Stock, par value $0.001; zero and 245,089,671 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	$	—	$	—
Common Stock, par value $0.001; 1,000,000,000 and 1,000,000,000 shares authorized, 243,305,848 and 64,943,238 issued and 243,011,280 and 64,832,609 outstanding as of September 30, 2023 and December 31, 2022, respectively	—		—
Additional paid–in capital	1,188		1,333
Retained deficit	(1,939)		(1,485)
Accumulated other comprehensive income (Note 17)	59		36
Total deficit	(692)		(116)
Total liabilities and deficit	$	2,532	$	2,637

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

4

GARRETT MOTION INC.

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended September 30,
	2023		2022
	(Dollars in millions)
Cash flows from operating activities:
Net income	$	209	$	278
Adjustments to reconcile net income to net cash provided by operating activities
Deferred income taxes	13		16
Depreciation	66		64
Amortization of deferred issuance costs	17		6
Interest payments, net of debt discount accretion	—		(19)
Loss on extinguishment of debt	—		5
Loss on remeasurement of forward purchase contract	13		—
Foreign exchange loss	—		4
Stock compensation expense	12		8
Pension expense	1		—
Change in fair value of derivatives	21		(54)
Other	7		2
Changes in assets and liabilities:
Accounts, notes and other receivables	(76)		(166)
Inventories	(30)		(80)
Other assets	2		13
Accounts payable	57		180
Accrued liabilities	26		(2)
Other liabilities	(8)		(17)
Net cash provided by operating activities	$	330	$	238
Cash flows from investing activities:
Expenditures for property, plant and equipment	(57)		(78)
Re-couponing of cross-currency swap contract	9		—
Net cash used for investing activities	$	(48)	$	(78)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of debt financing costs	667		—
Payments of long-term debt	(205)		(5)
Redemption of Series B Preferred Stock	—		(381)
Repurchases of Series A Preferred Stock	(580)		(4)
Repurchases of Common Stock	(178)		—
Payments of Additional Amounts for conversion of Series A Preferred Stock	(25)		—
Payments for preference dividends	(42)		(42)
Payments for debt and revolving facility financing costs	(2)		(4)
Other	(1)		—
Net cash used for financing activities	$	(366)	$	(436)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(1)		(27)
Net decrease in cash, cash equivalents and restricted cash	(85)		(303)
Cash, cash equivalents and restricted cash at beginning of the period	248		464
Cash, cash equivalents and restricted cash at end of the period	$	163	$	161
Supplemental cash flow disclosure:
Income taxes paid (net of refunds)	$	38	$	38
Interest paid	45		56

    

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement

5

GARRETT MOTION INC.

CONSOLIDATED INTERIM STATEMENTS OF EQUITY (DEFICIT)

(Unaudited)

	Series A Preferred Stock			Common Stock			Additional Paid-in Capital		Retained Deficit		Accumulated Other Comprehensive Income		Total Deficit
	Shares	Amount		Shares	Amount
	(in millions)
Balance at December 31, 2022	246	$	—	64	$	—	$	1,333	$	(1,485)	$	36	$	(116)
Net income	—	—		—	—		—		81		—		81
Other comprehensive loss, net of tax	—	—		—	—		—		—		(6)		(6)
Dividends	—	—		—	—		—		(42)		—		(42)
Stock-based compensation	—	—		—	—		3		—		—		3
Balance at March 31, 2023	246	$	—	64	$	—	$	1,336	$	(1,446)	$	30	$	(80)
Net income	—	—		—	—		—		71		—		71
Repurchases of Series A Preferred Stock	(70)	—		—	—		(366)		(201)		—		(567)
Repurchases of Common Stock	—	—		(2)	—		—		(18)		—		(18)
Excise tax on share repurchases	—	—		—	—		—		(6)		—		(6)
Other comprehensive loss, net of tax	—	—		—	—		—		—		(3)		(3)
Issuance of Common Stock for preference dividends	—	—		26	—		209		(209)		—		—
Conversion of Series A Preferred Stock to Common Stock	(176)	—		176	—		—		(25)		—		(25)
Stock-based compensation	—	—		—	—		5		—		—		5
Balance at June 30, 2023	—	$	—	264	$	—	$	1,184	$	(1,834)	$	27	$	(623)
Net income	—	—		—	—		—		57		—		57
Repurchases of Common Stock	—	—		(21)	—		—		(161)		—		(161)
Excise tax on share repurchases	—	—		—	—		—		(1)		—		(1)
Other comprehensive loss, net of tax	—	—		—	—		—		—		32		32
Stock-based compensation	—	—		—	—		4		—		—		4
Balance at September 30, 2023	—	$	—	243	$	—	$	1,188	$	(1,939)	$	59	$	(692)
	Series A Preferred Stock			Common Stock			Additional Paid-in Capital		Retained Deficit		Accumulated Other Comprehensive (Loss)/Income		Total Deficit
	Shares	Amount		Shares	Amount
	(in millions)
Balance at December 31, 2021	246	$	—	64	$	—	$	1,326	$	(1,790)	$	(4)	$	(468)
Net income	—	—		—	—		—		88		—		88
Repurchases of Series A Preferred Stock	—	—		—	—		(1)		(1)		—		(2)
Other comprehensive income, net of tax	—	—		—	—		—		—		23		23
Stock-based compensation	—	—		—	—		2		—		—		2
Balance at March 31, 2022	246	—		64	—		$	1,327	$	(1,703)	$	19	$	(357)
Net income	—	—		—	—		—		85		—		85
Repurchases of Series A Preferred Stock	—	—		—	—		(1)		—		—		(1)
Other comprehensive income, net of tax	—	—		—	—		—		—		39		39
Stock-based compensation	—	—		—	—		3		—		—		3
Balance at June 30, 2022	246	$	—	64	$	—	$	1,329	$	(1,618)	$	58	$	(231)
Net income	—	—		—	—		—		105		—		105
Repurchases of Series A Preferred Stock	—	—		—	—		(1)		—		—		(1)
Other comprehensive income, net of tax	—	—		—	—		—		—		64		64
Dividends declared	—	—		—	—		—		(42)		—		(42)
Stock-based compensation	—	—		—	—		3		—		—		3
Balance at September 30, 2022	246	$	—	64	$	—	$	1,331	$	(1,555)	$	122	$	(102)

The Notes to the Consolidated Interim Financial Statements are an integral part of this statement.

6

GARRETT MOTION INC.

NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS

(Unaudited)

(Dollars in millions, except per share amounts)

Note 1. Background and Basis of Presentation

Background

Garrett Motion Inc., (the “Company” or “Garrett”) designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket, as well as automotive software solutions. These OEMs in turn ship to consumers globally. We are a global technology leader with significant expertise in delivering products across gasoline, diesel, natural gas and electric (hybrid and fuel cell) power trains. These products are key enablers for fuel economy and emission standards compliance.

Basis of Presentation

The accompanying unaudited Consolidated Interim Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by United States generally accepted accounting principles (“GAAP”) for complete financial statements. The unaudited Consolidated Interim Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and accompanying notes for the year ended December 31, 2022 included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 14, 2023 (our “2022 Form 10-K”). The results of operations for the three and nine months ended September 30, 2023 and cash flows for the nine months ended September 30, 2023 should not necessarily be taken as indicative of the entire year. All amounts presented are in millions, except per share amounts.

We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday to minimize the potentially disruptive effects of quarterly closing on our business processes. For differences in actual closing dates that are material to year-over-year comparisons of quarterly or year-to-date results, such differences have been adjusted for the three months ended September 30, 2022. Our actual closing date for the three months ended September 30, 2022 was October 1, 2022. There was no difference in actual closing date for the three months ended September 30, 2023.

We evaluate segment reporting in accordance with ASC 280, Segment Reporting. We concluded that Garrett operates in a single operating segment and a single reportable segment based on the operating results available and evaluated regularly by the chief operating decision maker (“CODM”), which is our Chief Executive Officer, to make decisions about resource allocation and performance assessment. The CODM makes operational performance assessments and resource allocation decisions on a consolidated basis, inclusive of all of the Company’s products across channels and geographies.

The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods.

Capital Structure Transformation Transaction

On April 12, 2023, the Company entered into the Transaction (as defined in Note 15 below) to increase the attractiveness of the Company to investors, including simplifying the Company’s capital stock by converting all outstanding Series A Preferred Stock into a single class of Common Stock, subject to certain conditions.

In the Transaction, the Company repurchased and aggregate of 69,707,719 shares of Series A Preferred Stock from the C&O Investors (as defined below), and converted all remaining outstanding 175,337,712 shares of Series A Preferred Stock into an equivalent number of shares of Common Stock. The total amounts paid to holders of Series A Preferred Stock in connection with the Transaction included aggregate cash payments of $605 million and the issuance of an

7

additional 25,577,517 shares of Common Stock in settlement of accumulated and unpaid preference dividends on the Series A Preferred Stock through June 30, 2023. The Transaction was financed through a new Term Loan B for an aggregate principal amount of $700 million under the framework of the Company's existing credit agreement. See Note 15, Series A Preferred Stock.

The Company recorded the following amounts in the Consolidated Interim Financial Statements related to the repurchase and conversion of its Series A Preferred Stock:

	Movements for the Nine Months Ended
	September 30, 2023
Consolidated Interim Balance Sheet:	(Dollars in millions)
Cash and cash equivalents	$	(605)
Preferred stock, Common stock and Additional Paid-in capital	(157)
Retained earnings	(441)
	Nine Months Ended September 30, 2023
Consolidated Interim Statement of Operations:	(Dollars in millions)
Non-operating expenses	$	13

The Company also incurred $9 million of Transaction-related costs for the nine months ended September 30, 2023, primarily for legal and advisory services that are included in Selling, general and administrative expenses in the Consolidated Interim Statement of Operations. See Note 14, Long-term Debt and Credit Agreement for discussion on the new Term Loan B and Note 15, Series A Preferred Stock for further discussion of the Transaction.

Note 2. Summary of Significant Accounting Policies

The accounting policies of the Company are set forth in Note 3 to the Consolidated Financial Statements for the year ended December 31, 2022 included in our 2022 Form 10-K.

Recently Adopted Accounting Pronouncements

In September 2022, the FASB issued ASU 2022-04, Disclosure of Supplier Finance Program Obligations (Topic 405-50): Disclosure of Supplier Finance Purchase Obligations. The amendment in this update requires companies to disclose key terms of supplier financing programs used in connection with the purchase of goods and services, along with information about their obligations under these programs including a rollforward of those obligations. The Company adopted the new guidance as of January 1, 2023. See Note 10, Supplier Financing for disclosure related to the Company's supplier financing program obligations.

8

Note 3. Revenue Recognition and Contracts with Customers

Disaggregated Revenue

Net sales by region (determined based on country of shipment) and channel are as follows:

	Three Months Ended September 30, 2023								Three Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	147	$	54	$	2	$	203	$	134	$	54	$	1	$	189
Europe	382		45		9		436		381		41		6		428
Asia	287		13		5		305		288		14		6		308
Other	9		6		1		16		14		6		—		20
	$	825	$	118	$	17	$	960	$	817	$	115	$	13	$	945
	Nine Months Ended September 30, 2023								Nine Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	412	$	150	$	4	$	566	$	354	$	159	$	2	$	515
Europe	1,265		136		26		1,427		1,181		117		21		1,319
Asia	846		38		12		896		765		34		18		817
Other	33		18		1		52		36		18		—		54
	$	2,556	$	342	$	43	$	2,941	$	2,336	$	328	$	41	$	2,705

Contract Balances

The following table summarizes our contract assets and liabilities balances:

	2023		2022
	(Dollars in millions)
Contract assets—January 1	$	46	$	63
Contract assets—September 30	44		51
Change in contract assets—(Decrease)/Increase	$	(2)	$	(12)
Contract liabilities—January 1	$	(8)	$	(5)
Contract liabilities—September 30	(12)		(9)
Change in contract liabilities—(Increase)/Decrease	$	(4)	$	(4)

Note 4. Research, Development & Engineering

Garrett conducts research, development and engineering (“RD&E”) activities, which consist primarily of the development of new products and product applications. RD&E costs are charged to expense as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Customer reimbursements are netted against gross RD&E expenditures as they are considered a recovery of cost. Such costs are included in Cost of goods sold as follows:

9

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Research and development costs	$	42	$	38	$	128	$	112
Engineering-related expenses, net of customer (reimbursements) (1)	(3)		4		(8)		13
	$	39	$	42	$	120	$	125

(1)    Engineering-related expenses include customer reimbursements of $10 million and $6 million for the three months ended September 30, 2023 and 2022, respectively, and $34 million and $15 million for the nine months ended September 30, 2023 and 2022, respectively.

Note 5. Income Taxes

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Tax expense	$	13		$	26		$	70		$	83
Effective tax rate	18.6		%	19.8		%	25.1		%	23.0		%

The effective tax rate for the three months ended September 30, 2023 is lower than the effective rate for the three months ended September 30, 2022 primarily related to an increase in global research and development benefits, lower taxes on non-U.S. earnings partially offset by nondeductible expenses, and a prior year non-recurring decrease in withholding taxes on undistributed earnings.

The effective tax rate for the nine months ended September 30, 2023 is higher than the effective rate for the nine months ended September 30, 2022 primarily related to a prior year non-recurring decrease in withholding taxes on undistributed earnings and nondeductible expenses, partially offset by increase in global research and development benefit and lower taxes on non-U.S. earnings.

The effective tax rate for the three months ended September 30, 2023 was lower than the U.S. federal statutory rate of 21% primarily related to a decrease in the annual effective tax rate driven by lower taxes on international operations, partially offset by nondeductible transaction costs.

The effective tax rate for the nine months ended September 30, 2023 was higher than the U.S. federal statutory rate of 21% primarily related to nondeductible expenses and tax reserves, partially offset by lower taxes on non-U.S. earnings and global research and development benefits.

Note 6. Accounts, Notes and Other Receivables—Net

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Trade receivables	$	667	$	619
Notes receivable	111		105
Other receivables	89		88
	867		812
Less—Allowance for expected credit losses	(7)		(9)
	$	860	$	803

10

Trade receivables include $44 million and $46 million of unbilled customer contract asset balances as of September 30, 2023 and December 31, 2022, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. See Note 3, Revenue Recognition and Contracts with Customers.

Notes receivable is related to guaranteed bank notes without recourse that the Company receives in settlement of accounts receivables, primarily in the Asia Pacific region. See Note 7, Factoring and Notes Receivable for further information.

Note 7. Factoring and Notes Receivable

The Company enters into arrangements with financial institutions to sell eligible trade receivables. The receivables are sold without recourse and the Company accounts for these arrangements as true sales. The Company also receives guaranteed bank notes without recourse, in settlement of accounts receivables, primarily in the Asia Pacific region. The Company can hold the bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash. Bank notes sold to third-party financial institutions without recourse are likewise accounted for as true sales.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Eligible receivables sold without recourse	$	184	$	112	$	584	$	481
Guaranteed bank notes sold without recourse	41		35		41		102

The expenses related to the sale of trade receivables and guaranteed bank notes are recognized within Other expense, net in the Consolidated Interim Statements of Operations. Such expenses amounted to $1 million and $3 million for the three and nine months ended September 30, 2023, respectively, and were immaterial for the three and nine months ended September 30, 2022.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Receivables sold but not yet collected by the bank from the customer	$	7	$	5
Guaranteed bank notes sold but not yet collected by the bank from the customer	—		—

As of September 30, 2023 and December 31, 2022, the Company had no guaranteed bank notes pledged as collateral.

Note 8. Inventories—Net

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Raw materials	$	197	$	203
Work in process	24		18
Finished products	110		80
	331		301
Less—Reserves	(37)		(31)
	$	294	$	270

11

Note 9. Other Assets

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Advanced discounts to customers, non-current	$	41	$	51
Operating right-of-use assets (Note 13)	40		44
Income tax receivable	22		22
Pension and other employee related	4		4
Designated cross-currency swaps	71		74
Designated and undesignated derivatives	66		76
Other	11		10
	$	255	$	281

Note 10. Supplier Financing

The Company has supplier financing arrangements with two third-party financial institutions under which certain suppliers may factor their receivables from Garrett. The Company also enters into arrangements with banking institutions to issue bankers acceptance drafts in settlement of accounts payables, primarily in the Asia Pacific region. The bankers acceptance drafts, or guaranteed bank notes, have a contractual maturity of six months or less, and may be held by suppliers until maturity, transferred to their suppliers, or discounted with financial institutions in exchange for cash. The supplier financing obligations and guaranteed bank notes outstanding are recorded within Accounts payable in our Consolidated Interim Balance Sheet.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Supplier financing obligations outstanding with financial institutions	$	67	$	33
Guaranteed bank notes outstanding	172		171

Note 11. Accrued Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Customer pricing reserve	$	64	$	50
Compensation, benefit and other employee related	74		69
Repositioning	12		9
Product warranties and performance guarantees - short-term (Note 20)	17		18
Income and other taxes	55		39
Advanced discounts from suppliers, current	4		8
Customer advances and deferred income (1)	18		29
Accrued interest	25		13
Short-term lease liability (Note 13)	9		9
Accrued freight	13		9
Dividends payable	—		42
Designated and undesignated derivatives	8		8
Other (primarily operating expenses) (2)	13		17
	312		320

(1)Customer advances and deferred income include $12 million and $8 million of contract liabilities as of September 30, 2023 and December 31, 2022, respectively. See Note 3, Revenue Recognition and Contracts with Customers.

12

(2)Includes $3 million and $3 million of environmental liabilities as of September 30, 2023 and December 31, 2022, respectively.

The Company accrues repositioning costs related to projects to optimize its product costs and right-size our organizational structure. Expenses related to the repositioning accruals are included in Cost of goods sold and Selling, general and administrative expenses in our Consolidated Interim Statements of Operations.

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2022	$	9	$	—	$	9
Charges	13		2		15
Usage—cash	(10)		—		(10)
Non-cash asset write-offs	—		(2)		(2)
Balance at September 30, 2023	$	12	$	—	$	12

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2021	$	10	$	—	$	10
Charges	4		—		4
Usage—cash	(5)		—		(5)
Balance at September 30, 2022	$	9	$	—	$	9

Note 12. Other Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Income taxes	$	104	$	99
Pension and other employee related	17		21
Long-term lease liability (Note 13)	33		36
Advanced discounts from suppliers	3		6
Product warranties and performance guarantees – long-term (Note 20)	9		10
Environmental remediation – long term	12		14
Long-term accounts payable	7		8
Other	11		11
	196		205

Note 13. Leases

We have operating leases that primarily consist of real estate, machinery and equipment. Our leases have remaining lease terms of up to 15 years, some of which include options to extend the leases for up to two years, and some of which include options to terminate the leases within the year.

The components of lease expense are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Operating lease cost	$	4	$	4	$	12	$	12

13

Supplemental cash flow information related to operating leases is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	3	$	3	$	10	$	9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	—		2		2		4

Supplemental balance sheet information related to operating leases is as follows:

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Other assets	$	40	$	44
Accrued liabilities	9		9
Other liabilities	33		36

	September 30, 2023		December 31, 2022
Weighted-average remaining lease term (in years)	8.14		8.41
Weighted-average discount rate	5.69	%	5.61	%

Maturities of operating lease liabilities as of September 30, 2023 were as follows:

	(Dollars in millions)
2023	$	3
2024	10
2025	8
2026	6
2027	5
Thereafter	20
Total lease payments	52
Less imputed interest	(11)
	$	41

14

Note 14. Long-term Debt and Credit Agreements

The principal outstanding and carrying amounts of our long-term debt as of September 30, 2023 and December 31, 2022 are as follows:

	Due	Interest Rate	September 30, 2023		December 31, 2022
2021 Dollar Term Facility	4/30/2028	SOFR plus 351 bps	$	700	$	706
2023 Dollar Term Facility	4/30/2028	SOFR plus 450 bps	500		—
Euro Term Facility	4/30/2028	EURIBOR plus 350 bps	477		480
Total principal outstanding			1,677		1,186
Less: unamortized deferred financing costs			(48)		(31)
Less: current portion of long-term debt			(7)		(7)
Total long-term debt			$	1,622	$	1,148

Credit Facilities

On April 30, 2021, the Company entered into a credit agreement (as amended from time to time, the "Credit Agreement") providing for senior secured financing, consisting of a seven-year secured first-lien U.S. Dollar term loan facility initially in the amount of $715 million (the “2021 Dollar Term Facility”), a seven-year secured first-lien Euro term loan facility initially in the amount of €450 million (the “Euro Term Facility”) and a five-year senior secured first-lien revolving credit facility initially in the amount of $300 million providing for multi-currency revolving loans (the “Revolving Facility”). The maximum amount of borrowings available under the Revolving Facility was increased to $475 million in 2022.

On April 27, 2023, the Company entered into Amendment No. 3 (the "Third Amendment") to the Credit Agreement, which provided for additional financing consisting of a five-year secured first-lien U.S. Dollar term loan facility initially in the amount of $700 million (the “2023 Dollar Term Facility”, together with the 2021 Dollar Term Facility and Euro Term Facility, the "Term Loan Facilities", and together with the Revolving Facility, the "Credit Facilities"). The full amount of the 2023 Dollar Term Facility was drawn on June 6, 2023 (the "Closing Date"), and the proceeds were primarily used to finance the repurchases of the Series A Preferred Stock as part of the Transaction, and pay fees and expenses incurred in connection with the Third Amendment.

The 2023 Dollar Term Facility will mature on April 30, 2028. Prior to maturity, the 2023 Dollar Term Facility will be repaid quarterly in an amount equal to, during the first two years occurring after the Closing Date, 7.50% per annum of the aggregate principal amount, and thereafter, 10.00% per annum. The Term Borrowers may also prepay the 2023 Dollar Term Facility at any time in whole or in part without premium or penalty, subject to certain exceptions (including for (i) customary breakage and redeployment costs in the case of prepayment of term benchmark rate loans and (ii) 2023 Dollar Term Facility repricing events occurring during the period from the Closing Date to the date that is twelve months following the Closing Date).

The Third Amendment also provided for (i) an increase in the maximum borrowing amount under the Revolving Facility by $95 million (the “Incremental Revolving Commitment”) to an aggregate amount of $570 million; and (ii) an extension of the maturity date for the Revolving Facility by two years from April 30, 2026 to April 30, 2028 (or January 30, 2028 if any of the currently outstanding term loans or term loans under the 2023 Dollar Term Facility maturing as of April 30, 2028 remain outstanding as of such date). The Incremental Revolving Commitment has the same terms and is generally subject to the same conditions applicable to the existing revolving facility under the Credit Agreement, except for fees paid in connection with the arrangement of the increased amount.

Under the Revolving Facility, the Company may use up to $125 million for the issuance of letters of credit to its subsidiaries. Letters of credit are available for issuance under the Credit Agreement on terms and conditions customary for financings of this kind, which issuances reduce availability under the Revolving Facility. As of September 30, 2023, the Company had no loans outstanding under the Revolving Facility, no outstanding letters of credit, and available borrowing capacity of approximately $570 million.

Separate from the Revolving Facility, the Company has a bilateral letter of credit facility in the amount of $15 million, which matures on April 30, 2026. As of September 30, 2023, the Company had $12 million utilized and $3 million of remaining available capacity under such facility.

15

Minimum scheduled principal repayments of the Credit Facilities as of September 30, 2023 are as follow:

	September 30, 2023
	(Dollars in millions)
2023	$	2
2024	7
2025	7
2026	17
2027	77
Thereafter	1,567
Total debt payments	$	1,677

Interest Rate and Fees

The 2021 Dollar Term Facility is subject to an interest rate, at our option, of either (a) an alternate base rate (“ABR”) (which shall not be less than 1.50%) or (b) an adjusted SOFR rate (“SOFR”) (which shall not be less than 0.50%), in each case, plus an applicable margin equal to 3.51% in the case of SOFR loans and 2.25% in the case of ABR loans. The Euro Term Facility is subject to an interest rate equal to an adjusted EURIBOR rate (which shall not be less than zero) plus an applicable margin equal to 3.50%. Interest payments with respect to the 2021 Dollar and Euro Term Facilities are required either on a quarterly basis (for ABR loans) or at the end of each interest period (for SOFR and EURIBOR loans) or, if the duration of the applicable interest period exceeds three months, then every three months.

The 2023 Dollar Term Facility will bear interest, at the Term Borrowers’ election, at a rate per annum equal to (i) SOFR (subject to a 0.50% floor) plus the applicable margin or (ii) the base rate plus the applicable margin. The applicable margin for loans under the 2023 Dollar Term Facility is 4.50% for SOFR loans and 3.50% for base rate loans.

The Revolving Facility is subject to an interest rate comprised of an applicable benchmark rate as provided under the Credit Agreement (which shall not be less than 1.00% if such benchmark is the ABR rate and not less than 0.00% in the case of other applicable benchmark rates) that is selected based on the currency in which borrowings are outstanding thereunder, in each case, plus an applicable margin, that may vary based on our leverage ratio.

In addition to paying interest on outstanding borrowings under the Revolving Facility, we are also required to pay a quarterly commitment fee based on the average daily unused portion of the Revolving Facility during such quarter, which is determined by our leverage ratio and ranges from 0.25% to 0.50% per annum.

Prepayments

The Credit Agreement contains certain mandatory prepayment provisions in the event that we incur certain types of indebtedness, receive net cash proceeds from certain non-ordinary course asset sales or other dispositions of property, or have excess cash flow (calculated on an annual basis with the required prepayment equal to 50%, 25% or 0% of such excess cash flow, subject to compliance with certain leverage ratios), in each case subject to terms and conditions customary for financings of this kind.

On July 31, 2023, the Company made an early repayment in the amount of $200 million on the 2023 Dollar Term Facility. The early repayment resulted in incremental amortization on debt issuance cost in the amount of $9 million, included within Interest Expense in the Consolidated Interim Statement of Operations.

Certain Covenants

The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The Revolving Facility also contains a financial covenant requiring the maintenance of a consolidated total leverage ratio of not greater than 4.7 times as of the end of each fiscal quarter if, on the last day of any such fiscal quarter, the aggregate amount of loans and letters of credit (excluding backstopped or cash collateralized letters of credit and other letters of credit with an aggregate face amount not exceeding $30 million) outstanding under the Revolving Facility exceeds 35% of the aggregate commitments in effect thereunder on such date. As of September 30, 2023, the Company was in compliance with all covenants.

16

Note 15. Series A Preferred Stock

On April 12, 2023 (the “Transaction Date”), the Company entered into separate definitive agreements (the “Agreements”) with each of Centerbridge Partners, L.P. and funds managed by Oaktree Capital Management, L.P. (collectively, the “C&O Investors”) to effect a series of integrated transactions (collectively the “Transaction”) designed to increase the attractiveness of the Company to investors, including by simplifying the Company’s capital structure by converting all outstanding Series A Preferred Stock into a single class of Common Stock, subject to certain conditions.

As part of the Agreements, the holders of a majority of the outstanding shares of the Series A Preferred Stock authorized and approved the amendment and restatement of the certificate of designations for the Series A Preferred Stock (as amended, the “Certificate of Designations”) to, among other things, require the conversion of all shares of Series A Preferred Stock into shares of the Company’s common stock (the “2023 Conversion”), subject to the repurchase by the Company of a portion of the shares of Series A Preferred Stock held by the C&O Investors (the “Series A Repurchase”).

Under the terms of the Agreements, the Company agreed to repurchase a total of $570 million (“Base Repurchase Price”) of shares of Series A Preferred Stock from the C&O Investors at a cash price of $8.10 per share which was subsequently adjusted to equal the volume-weighted average price of the Common Stock for the fifteen trading days following the announcement of the transactions (the “15 Days VWAP”), subject to a minimum price of $7.875 per share and a maximum price of $8.50 per share. The 15 Days VWAP was subsequently established at a value of $8.177 per share.

As part of the Transaction, all holders of Series A Preferred Stock, including the C&O Investors, received approximately 0.104379 shares of Common Stock, being an amount equal to $0.853509 per share of Series A Preferred Stock, valued at the 15 Days VWAP, representing accumulated and unpaid preference dividends on each share of Series A Preferred Stock through June 30, 2023 (the “Accumulated Dividends”), as well as $0.144375 per share of Series A Preferred Stock, representing the preference dividends that would have accrued on the Series A Preferred Stock through September 30, 2023 (the “Additional Amounts”).

As part of the Transaction, following the effectiveness of the Certificate of Designations which occurred on June 6, 2023, the Company completed all steps of the Transaction as follows:

•The Company paid $580 million to the C&O Investors in connection with the repurchase of 69,707,719 shares of Series A Preferred Stock, comprising of the Base Repurchase Price as well as $10 million ($0.144375 for each repurchased share) in consideration of the Additional Amounts on the repurchased shares of Series A Preferred Stock.

•The remaining 175,337,712 shares of Series A Preferred Stock outstanding following such repurchase were converted into 175,337,712 shares of Common Stock (in accordance with the customary procedures of the Company’s transfer agent, for shares held in registered form, and of the Depository Trust Company, for shares held in street name). Following the completion of the 2023 Conversion, trading of the Series A Preferred Stock on Nasdaq was suspended;

•As part of the 2023 Conversion, the Company also paid $25 million ($0.144375 for each converted share) to the holders of Series A Preferred Stock in consideration of the Additional Amounts on the shares of Series A Preferred Stock that were converted; and

•Issued 25,577,517 shares of Common Stock to all holders of Series A Preferred Stock (equal to $0.853509 per share, valued at the 15 Days VWAP, adjusted to avoid the issuance of fractional shares of Common Stock), in consideration of the Accumulated Dividends of an aggregate amount of $209 million. Cash payments for fractional shares were immaterial.

The Agreements were accounted for as freestanding physically settled forward purchase contracts. The Agreements were initially recorded at fair value and then remeasured through earnings until the establishment of the 15 Days VWAP, whereupon the Agreements were subsequently measured based on the amount of consideration to be paid at settlement. A Monte-Carlo simulation model was used to determine the Transaction Date fair value of the Agreements by simulating a range of possible future stock prices for the Company through the expected settlement date of the Agreements. The significant assumptions utilized in estimating the fair value of the Agreements include: (i) a dividend yield of 0.0%; (ii) an expected volatility of 40.0%; (iii) a risk-free interest rate of 4.23% based on observed interest rates from the Treasury Constant Maturity yield curve consistent with the simulation term; and (iv) a starting share price of $8.25 based on the market price of the Company’s common stock as of the Transaction Date.

17

The initial fair value of the Agreements represented a forward purchase liability of $4 million. A loss of $13 million was recognized in Non-operating expense in the Consolidated Interim Statement of Operations to reflect the subsequent remeasurement of fair value of the Agreements due to changes in the market price of the Company’s Common Stock. The difference between the fair value of consideration transferred under the Agreements and the carrying value of the repurchased Series A Preferred Stock, amounting to $201 million, was recorded to Retained Deficit as a deemed dividend on the repurchase of shares of Series A Preferred Stock from the C&O Investors as part of the Transaction. A liability for excise tax, amounting to $6 million, was also recorded to Retained Deficit as a deemed dividend.

In connection with the 2023 Conversion, the Company also recognized a deemed dividend on the 2023 Conversion for $25 million, corresponding to the Additional Amounts paid to the holders of Series A Preferred Stock on the shares of Series A Preferred Stock that were converted.

As part of the Agreements, the C&O Investors have agreed with the Company to certain changes to their governance rights under the Company’s governance documents, including a reduction of their existing board nomination rights, as well as lock-up restrictions on their equity securities of the Company for up to twelve months, and certain limits on their ability to purchase additional equity securities of the Company and to voting limitations, in each case for a period of up to eighteen months.

On April 12, 2023, the Company also announced an increase in its share repurchase authorization to $250 million. Under the share repurchase program, the Company may repurchase shares of Common Stock in open market transactions, privately negotiated purchases and other transactions from time to time.

The following table summarizes the effects of the Transaction on the Consolidated Interim Balance Sheet as of September 30, 2023 and the Consolidated Interim Statement of Operations and Consolidated Interim Statement of Cash Flows for the nine months ended September 30, 2023:

	Series A Repurchase		2023 Conversion		Settlement of Accumulated Dividends		Excise tax on share repurchase		Total
	(Dollars in millions)
Consolidated Interim Balance Sheet - increase/(decrease):
Cash and cash equivalents	$	(580)	$	(25)	$	—	$	—	$	(605)
Accrued liabilities	—		—		—		6		6
Preferred Stock	—		—		—		—		—
Common Stock	—		—		—		—		—
Additional Paid-in capital	(366)		—		209		—		(157)
Retained earnings	(201)		(25)		(209)		(6)		(441)
Consolidated Interim Statement of Operations:
Non-operating expenses	13		—		—		—		13
Consolidated Interim Statement of Cash Flows
Repurchases of Series A Preferred Stock	(580)		—		—		—		(580)
Payments for Additional Amounts for conversion of Series A Preferred Stock	—		(25)		—		—		(25)

The Company has also incurred $9 million of Transaction-related costs for the nine months ended September 30, 2023, primarily for legal and advisory services that are included in Selling, general and administrative expenses in the Consolidated Interim Statement of Operations.

Note 16. Financial Instruments and Fair Value Measures

Our credit, market and foreign currency risk management policies are described in Note 19, Financial Instruments and Fair Value Measures, to the Consolidated Financial Statements for the year ended December 31, 2022 included in our 2022 Form 10-K. As of September 30, 2023 and December 31, 2022, we had contracts with aggregate gross notional amounts of $2,884 million and $2,621 million, respectively, to hedge interest rates and foreign currencies, principally the U.S. Dollar, Swiss Franc, British Pound, Euro, Chinese Yuan, Japanese Yen, Mexican Peso, New Romanian Leu, Czech Koruna, Australian Dollar and Korean Won.

18

Fair Value of Financial Instruments

The FASB’s accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2023 and December 31, 2022:

					Fair Value
	Notional Amounts				Assets					Liabilities
	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022			September 30, 2023		December 31, 2022
Designated instruments:
Designated forward currency exchange contracts	$	449	$	565	$	15	$	22	(a)	$	6	$	6	(c)
Designated cross-currency swaps	1,015		715		71		74		(b)	—		—
Designated interest-rate swaps	200		—		1		—		(b)	—		—
Total designated instruments	1,664		1,280		87		96			6		6
Undesignated instruments:
Undesignated interest rate swaps	879		1,024		65		76		(b)	—		—
Undesignated forward currency exchange contracts	341		317		3		4		(a)	2		2		(c)
Total undesignated instruments	1,220		1,341		68		80			2		2
Total designated and undesignated instruments	$	2,884	$	2,621	$	155	$	176		$	8	$	8

(a) Recorded within Other current assets

(b) Recorded within Other assets

(c) Recorded within Accrued liabilities

As of September 30, 2023, the Company had outstanding interest rate swaps with aggregate notional amounts of €830 million ($879 million based on September 30, 2023 foreign exchange rates) and $200 million, with maturities of April 2024, July 2024, October 2024, April 2025, April 2026, April 2027 and April 2028. The Company uses interest rate swaps specifically to mitigate variable interest risk exposure on its long-term debt portfolio. The $200 million interest rate swaps have been designated as cash flow hedges. The designated interest rate swaps' fair value were net assets of $1 million as of September 30, 2023.

The Company executed cross-currency swaps which have been designated as net investment hedges of its Euro-denominated operations and cash flow hedges to hedge the foreign currency exposure from foreign currency-denominated debt. In May 2023, the Company re-couponed the cross-currency swap contracts which have been designated as net investment hedges and received a cash settlement of $9 million. As of September 30, 2023, an aggregate notional amount of €615 million was designated as net investment hedges of the Company’s investment in Euro-denominated operations and €280 million was designated as cash flow hedges. The cross-currency swaps’ fair values were net assets of $71 million as of September 30, 2023. Our Consolidated Interim Statements of Comprehensive Income include Changes in fair value of net investment hedges and cash flow hedges, net of tax, of $20 million and $18 million, during the three and nine months ended September 30, 2023, respectively, related to these designated cross-currency swaps. No ineffectiveness has been recorded on the designated cross-currency hedges.

The Company's forward currency exchange contract under our cash flow hedging program are assessed as highly effective and are designated as cash flow hedges. Gains and losses on derivatives qualifying as cash flow hedges are recorded in Accumulated other comprehensive income until the underlying transactions are recognized in earnings.

The foreign currency exchange, interest rate swap and cross-currency swap contracts are valued using market observable inputs. As such, these derivative instruments are classified within Level 2. The assumptions used in measuring the fair value of the cross-currency swap are considered Level 2 inputs, which are based upon market-observable interest rate curves, cross-currency basis curves, credit default swap curves, and foreign exchange rates.

19

The carrying value of Cash, cash equivalents and restricted cash, Account receivables and Notes and Other receivables contained in the Consolidated Interim Balance Sheet approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	September 30, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(Dollars in millions)
Term Loan Facilities	$	1,629	$	1,671	$	1,156	$	1,151

The Company determined the fair value of certain of its long-term debt and related current maturities utilizing transactions in the listed markets for similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered Level 2.

Note 17. Accumulated Other Comprehensive Income

The changes in Accumulated Other Comprehensive Income by component are set forth below:

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2022	$	(44)	$	13	$	85	$	(18)	$	36
Other comprehensive income before reclassifications	8		17		18		—		43
Amounts reclassified from accumulated other comprehensive income	—		(20)		—		—		(20)
Net current period other comprehensive income	8		(3)		18		—		23
Balance at September 30, 2023	$	(36)	$	10	$	103	$	(18)	$	59

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2021	$	(43)	$	7	$	41	$	(9)	$	(4)
Other comprehensive income before reclassifications	13		43		87		—		143
Amounts reclassified from accumulated other comprehensive income	—		(17)		—		—		(17)
Net current period other comprehensive income	13		26		87		—		126
Balance at September 30, 2022	$	(30)	$	33	$	128	$	(9)	$	122

20

Note 18. Earnings Per Share

For the three months ended September 30, 2023, basic earnings per share ("EPS") is computed using the weighted-average number of common shares outstanding during the period.

For the nine months ended September 30, 2023 as well as the three and nine months ended September 30, 2022, basic earnings per share is calculated using the two-class method as our Series A Preferred Stock, which was converted into Common Stock pursuant to the Transaction, was considered a participating security. The two-class method requires an allocation of earnings to all securities that participate in dividends with common shares, such as our Series A Preferred Stock, to the extent that each security may share in the entity’s earnings. Basic earnings per share are then calculated by dividing undistributed earnings allocated to common stock by the weighted average number of common shares outstanding for the period. The Series A Preferred Stock was not included in the computation of basic earnings per share in periods in which we have a net loss, as the Series A Preferred Stock was not contractually obligated to share in our net losses.

Diluted earnings per share for the three months ended September 30, 2023 is calculated based on the weighted-average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method. Diluted earnings per share for the nine months ended September 30, 2023 as well as the three and nine months ended September 30, 2022 is calculated using the more dilutive of the two-class or if-converted methods. The two-class method uses net income available to common shareholders and assumes conversion of all potential shares other than the participating securities. The if-converted method uses net income and assumes conversion of all potential shares including the participating securities.

The details of the EPS calculations for the three and nine months ended September 30, 2023 and 2022 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions except per share)
Basic earnings per share:
Net income	$	57	$	105	$	209	$	278
Less: preferred stock dividend	—		(40)		(80)		(117)
Less: preferred stock deemed dividends	—		—		(232)		—
Net (loss) income available for distribution	57		65		(103)		161
Less: earnings allocated to participating securities	—		(51)		—		(127)
Net (loss) income available to common shareholders	$	57	$	14	$	(103)	$	34
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
EPS – Basic	$	0.23	$	0.21	$	(0.73)	$	0.52
Diluted earnings per share:
Method used:			Two-class		Two-class		Two-class
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
Dilutive effect of unvested RSUs and other contingently issuable shares	1,493,003		429,400		—		283,723
Weighted average common shares outstanding – Diluted	252,381,719		65,250,287		141,745,701		65,118,021
EPS – Diluted	$	0.23	$	0.21	$	(0.73)	$	0.52

For the periods where a net loss attributable to common shareholders is present, dilutive securities have been excluded from the calculation of diluted net loss per share attributable to common stockholders as including them would have been anti-dilutive. For the nine months ended September 30, 2023, the weighted-average number of unvested RSUs and other contingently issuable shares excluded from the computations was 1,349,442 shares.

21

Note 19. Related Party Transactions

We lease certain facilities and receive property maintenance services from Honeywell International Inc. (“Honeywell”), which is a holder of our Common Stock and was also a holder of our Series A Preferred Stock prior to the 2023 Conversion as discussed below and in Note 15, Series A Preferred Stock. We also contract with Honeywell for the occasional purchase of certain goods and services. Lease and service agreements were made at commercial terms prevalent in the market at the time they were executed. Honeywell is not considered a related party subsequent to the 2023 Conversion.

Our payments under the agreements with Honeywell during the period that Honeywell was considered a related party are as follow:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Payments under agreements with Honeywell	$	—	$	2	$	2	$	6

Our payments under the agreements with Honeywell are included in Cost of goods sold and Selling, general and administrative expenses in our Consolidated Interim Statements of Operations. Related to the agreements with Honeywell, our Consolidated Balance Sheet at December 31, 2022 includes liabilities of $10 million. Liability balances are primarily related to lease contracts of $7 million as of December 31, 2022.

As discussed in Note 15, Series A Preferred Stock, in order to effect the Transaction, on April 12, 2023, the Company entered into separate definitive agreements with each of Centerbridge Partners, L.P. (“Centerbridge”) and funds managed by Oaktree Capital Management, L.P. (“Oaktree”), each of which is a holder of our Common Stock and appoints a director to our Board of Directors. Additionally, Mr. Kevin Mahony, who serves as a Managing Director of Centerbridge, and Mr. Steven Tesoriere, who serves as a Managing Director of Oaktree, have been appointed to our Board of Directors as designees of Centerbridge and Oaktree, respectively. As described more fully in Note 15, Series A Preferred Stock, in connection with the Transaction, we paid to Centerbridge and Oaktree an aggregate of approximately $570 million for the repurchase of shares of Series A Preferred Stock, plus an aggregate of approximately $10 million and 7,276,036 shares of Common Stock representing the Additional Amounts and Accumulated Dividends in respect of the repurchased shares of Series A Preferred Stock. Additionally, in connection with the conversion of the Series A Preferred Stock, we issued to Centerbridge and Oaktree an aggregate of 65,334,277 shares of Common Stock, plus Additional Amounts and Accumulated Dividends of approximately $9 million and 6,819,540 shares of Common Stock.

In connection with the conversion of our Series A Preferred Stock, we issued to Honeywell, as a holder of our Series A Preferred Stock, 4,196,330 shares of Common Stock upon the conversion of an equivalent number of shares of Series A Preferred Stock, plus Additional Amounts and Accumulated Dividends of approximately $1 million and 438,009 shares of Common Stock.

Additionally, Mr. John Petry, a director on our Board, serves as Managing Member of Sessa Capital (Master), L.P., which indirectly held shares of our Series A Preferred Stock prior to the conversion. In connection with the conversion of our Series A Preferred Stock, we issued to Sessa Capital and its affiliates, as holder of our Series A Preferred Stock, 16,592,384 shares of Common Stock upon the conversion of an equivalent number of shares of Series A Preferred Stock, plus Additional Amounts and Accumulated Dividends of approximately $2 million and 1,731,900 shares of Common Stock.

Note 20. Commitments and Contingencies

Securities Litigation

On September 25, 2020, a putative securities class action complaint was filed against Garrett Motion Inc. and certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. The case bears the caption: Steven Husson, Individually and On Behalf of All Others Similarly Situated, v. Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-07992-JPC (SDNY) (the “Husson Action”). The Husson Action asserted claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 as amended (the "Exchange Act"), for securities fraud and control person liability. On September 28, 2020, the

22

plaintiff sought to voluntarily dismiss his claim against Garrett Motion Inc. in light of the Company’s bankruptcy; this request was granted.

On October 5, 2020, another putative securities class action complaint was filed against certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. This case bears the caption: The Gabelli Asset Fund, The Gabelli Dividend & Income Trust, The Gabelli Value 25 Fund Inc., The Gabelli Equity Trust Inc., SM Investors LP and SM Investors II LP, on behalf of themselves and all others similarly situated, v. Su Ping Lu, Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Craig Balis, Thierry Mabru, Russell James, Carlos M. Cardoso, Maura J. Clark, Courtney M. Enghauser, Susan L. Main, Carsten Reinhardt, and Scott A. Tozier, Case No. 1:20-cv-08296-JPC (SDNY) (the “Gabelli Action”). The Gabelli Action also asserted claims under Sections 10(b) and 20(a) of the Exchange Act.

On November 5, 2020, another putative securities class action complaint was filed against certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. This case bears the caption: Joseph Froehlich, Individually and On Behalf of All Others Similarly Situated, v. Olivier Rabiller, Allesandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-09279-JPC (SDNY) (the “Froehlich Action”). The Froehlich Action also asserted claims under Sections 10(b) and 20(a) of the Exchange Act.

The actions were assigned to Judge John P. Cronan. On November 24, 2020, competing motions were filed seeking the appointment of lead plaintiff and lead counsel and the consolidation of the Husson, Gabelli, and Froehlich Actions.

On December 8, 2020, counsel for the plaintiffs in the Gabelli Action — the Entwistle & Cappucci law firm — filed an unopposed stipulation and proposed order that would (1) appoint the plaintiffs in the Gabelli Action — the “Gabelli Entities” — the lead plaintiffs; (2) would appoint Entwistle & Cappucci as lead counsel for the plaintiff class; and (3) consolidate the Gabelli Action, the Husson Action, and the Froehlich Action (the “Consolidated D&O Action”). On January 21, 2021, the Court granted the motion to consolidate the actions and granted the Gabelli Entities’ motions for appointment as lead plaintiff and for selection of lead counsel. On February 25, 2021, plaintiffs filed a Consolidated Amended Complaint.

The Company’s insurer, AIG, has accepted the defense, subject to the customary reservation of rights.

The Company agreed with the Gabelli Entities and their lead counsel to permit a class claim to be recognized in the bankruptcy court and to have securities claims against the Company to be litigated in the district court alongside the Consolidated D&O Action. The Gabelli Entities have agreed that any recoveries against Garrett Motion Inc. on account of securities claims litigated through the class claim are limited to available insurance policy proceeds. On July 2, 2021, the bankruptcy court entered an order approving the joint request from the Company and the Gabelli Entities to handle the securities claims against Garrett Motion Inc. in this manner.

The Gabelli Entities were authorized and, on July 22, 2021, filed a second amended complaint to add claims against Garrett Motion Inc. On August 11, 2021, Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Russell James, Carlos Cardoso, Maura Clark, Courtney Enghauser, Susan Main, Carsten Reinhardt, and Scott Tozier filed a motion to dismiss with respect to claims asserted against them. On the same day, Su Ping Lu, who is represented separately, filed a motion to dismiss with respect to the claims asserted against her. Lead plaintiffs’ opposition to the motions to dismiss was filed on October 26, 2021, and the defendant's reply briefs were filed on or before December 8, 2021. On March 31, 2022, the judge dismissed the complaints entirely - Su Ping Lu's motion to dismiss was granted with prejudice while the court granted the plaintiffs 30 days to file a third amended complaint against the Company and the other defendants.

On May 2, 2022, the plaintiffs filed a Third Amended Complaint (“TAC”) against all of the foregoing Defendants apart from Alessandro Gili and Su Ping Lu. On June 24, 2022, defendants moved to dismiss the TAC in its entirety, with prejudice. Plaintiffs filed their opposition on August 16, 2022, and defendants filed their reply brief on September 23, 2022. On September 22, 2022, the action was reassigned from Judge John P. Cronan to Judge Jennifer L. Rochon, who was recently appointed. On March 31, 2023, the action was dismissed with prejudice. The plaintiffs filed an appeal and the defendants' opposition is due on October 31, 2023.

Brazilian Tax Matter

In September 2020, the Brazilian tax authorities issued an infraction notice against Garrett Motion Industria Automotiva Brasil Ltda, challenging the use of certain tax credits (“Befiex Credits”) between January 2017 and February 2020. The infraction notice results in a loss contingency that may or may not ultimately be incurred by the Company. The

23

estimated total amount of the contingency as of September 30, 2023 was $37 million including penalties and interest. The Company believes, based on management’s assessment and the advice of external legal counsel, that it has meritorious arguments in connection with the infraction notice and any liability for the infraction notice is currently not probable. Accordingly, no accrual is required at this time.

Warranties and Guarantees

In the normal course of business, we issue product warranties and product performance guarantees. We accrue for the estimated cost of product warranties and performance guarantees based on contract terms and historical experience at the time of sale to the customer. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. Product warranties and product performance guarantees are included in Accrued Liabilities and Other Liabilities. The following table summarizes information concerning our recorded obligations for product warranties and product performance guarantees.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Warranty and product performance guarantees at beginning of period	$	27	$	30	$	28	$	32
Accruals for warranties/guarantees issued during the year	2		3		8		10
Settlement of warranty/guarantee claims	(2)		(2)		(9)		(10)
Foreign currency translation	(1)		(2)		(1)		(3)
Warranty and product performance guarantees at end of period	$	26	$	29	$	26	$	29

Other Commitments and Contingencies

We are subject to other lawsuits, investigations and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurring and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts.

Note 21. Pension Benefits

We sponsor several funded U.S. and non-U.S. defined benefit pension plans. Significant plans outside the U.S. are in Switzerland and Ireland. Other pension plans outside the U.S. are not material to the Company, either individually or in the aggregate.

Our general funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. We are not required to make any contributions to our U.S. pension plan in 2023. We expect to make contributions of cash and/or marketable securities of approximately $7 million to our non-U.S. pension plans to satisfy regulatory funding standards in 2023, of which $6 million has been contributed as of September 30, 2023.

24

Net periodic benefit costs for our significant defined benefit plans include the following components:

	Three Months Ended September 30,								Nine Months Ended September 30,
	U.S. Plans				Non-U.S. Plan				U.S. Plans				Non-U.S. Plan
	2023		2022		2023		2022		2023		2022		2023		2022
	(Dollars in millions)
Service cost	$	—	$	—	$	1	$	2	$	—	$	1	$	4	$	5
Interest cost	2		1		1		—		6		4		4		1
Expected return on plan assets	(2)		(2)		(2)		(2)		(6)		(6)		(6)		(5)
Amortization of prior service (credit)	—		—		—		—		—		—		(1)		—
	$	—	$	(1)	$	—	$	—	$	—	$	(1)	$	1	$	1

For both our U.S. and non-U.S. defined benefit pension plans, we estimate the service and interest cost components of net periodic benefit (income) cost by utilizing a full yield curve approach in the estimation of these cost components by applying the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows. This approach provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations, which we refer to as our “MD&A,” should be read in conjunction with our Consolidated Interim Financial Statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the audited annual Consolidated Financial Statements for the year ended December 31, 2022, included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 14, 2023 (our “2022 Form 10-K”). Some of the information contained in this MD&A or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many important factors, including those set forth in the “Risk Factors” section of our 2022 Form 10-K and this Quarterly Report on Form 10-Q, our actual results could differ materially from the results described in, or implied, by these forward-looking statements.

The following MD&A is intended to help you understand the results of operations and financial condition of Garrett Motion Inc., for the three and nine months ended September 30, 2023.

Executive Summary

For the three months ended September 30, 2023, net sales were $960 million, an increase compared to prior year of $15 million or 2%, including a favorable impact of $21 million or 3% from foreign currency translation. The increase was driven by ramp up of new products in small gasoline engine applications, offset by unfavorable product mix dynamics from demand softness for diesel and commercial vehicle applications due to global macro economic conditions.

Light vehicle product sales (which were comprised of diesel and gasoline products, including products for passenger cars, SUVs, light trucks, and other products) accounted for approximately 70% of our revenues. Commercial vehicle product sales (products for on- and off- highway trucks, construction, agriculture and power-generation machines) accounted for 16% of our revenues, while aftermarket and other products contributed 14% of our revenues. Approximately 45% of our revenues came from sales to customers located in Europe, 32% from sales to customers located in Asia, 21% from sales to customers in North America, and 2% from sales to customers in other international markets.

For the three months ended September 30, 2023, we repurchased $161 million of Common Stock in connection with our share repurchase program. As of September 30, 2023, we had $72 million of the authorized repurchase value remaining under our share repurchase program.

On July 31, 2023, we made an early debt repayment in the amount of $200 million on our 2023 Dollar Term Facility.

Disaggregated Revenue

The following tables show our revenues by geographic region and product line for the three and nine months ended September 30, 2023 and 2022, respectively.

By Region

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
United States	$	203	21%	$	189	20%	$	566	19%	$	515	19%
Europe	436		45%	428		45%	1,427		49%	1,319		49%
Asia	305		32%	308		33%	896		30%	817		30%
Other	16		2%	20		2%	52		2%	54		2%
Total	$	960		$	945		$	2,941		$	2,705

26

By Product Line

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Diesel	$	229	24%	$	238	25%	$	751	26%	$	729	27%
Gas	441		46%	401		43%	1,299		44%	1,109		41%
Commercial Vehicle	156		16%	178		19%	507		17%	498		18%
Aftermarket	118		12%	115		12%	342		12%	328		12%
Other	16		2%	13		1%	42		1%	41		2%
Total	$	960		$	945		$	2,941		$	2,705

Results of Operations for the Three and Nine Months Ended September 30, 2023

Net Sales

	Three Months Ended September 30,					Nine Months Ended September 30,
	2023			2022		2023			2022
	(Dollars in millions)
Net sales	$	960		$	945	$	2,941		$	2,705
% change compared with prior period	1.6		%			8.7		%

For the three months ended September 30, 2023, net sales increased compared to prior year by $15 million or 2%, including a favorable impact of $21 million or 3% due to foreign currency translation driven by higher Euro-to-US dollar exchange rates and partially offset by lower Chinese yuan-to-US dollar exchange rates. The increase was driven by ramp up of new products in small gasoline engine applications, offset by unfavorable product mix from demand softness for diesel and commercial vehicle applications due to global macro economic conditions.

Gasoline product sales increased by $40 million or 10% (including a favorable impact of $3 million or 1% due to foreign currency translation), primarily due to strong performance in Asia and North America related to product ramp-ups.

Diesel product sales decreased by $9 million or 4% (including a favorable impact of $12 million or 5% due to foreign currency translation), primarily driven by demand softness in India and China, due to program phase out and the negative impact of macro economic dynamics, respectively.

Commercial vehicle sales decreased by $22 million or 13% (including a favorable impact of $2 million or 1% due to foreign currency translation), primarily driven by demand softness influenced by the global economic environment combined with inventory build-up by some customers during prior quarters.

Aftermarket sales improved by $3 million or 3% (including a favorable impact of $3 million or 3% due to foreign currency translation), primarily due to favorable aftermarket conditions and demand for replacement parts in Europe and Asia Pacific, offset by softer sales in North America and Brazil.

27

For the nine months ended September 30, 2023, net sales increased compared to prior year by $236 million or 9%, including an unfavorable impact of $32 million or 1% due to foreign currency translation driven by lower Chinese yuan-to-US dollar and lower Euro-to-US dollar exchange rates. This increase was driven by higher volumes as markets recovered from the semiconductor shortages experienced in the prior year coupled with strong demand for new product launches and ramp ups, and inflation recoveries net of pricing across all product lines.

Gasoline product sales increased by $190 million or 17% (including an unfavorable impact of $25 million or 2% due to foreign currency translation), primarily driven by the industry recovery from prior year’s global semiconductor shortages and COVID-related lockdown measures in China combined with new product launches and ramp ups across all regions.

Diesel product sales increased by $22 million or 3% (including a favorable impact of $1 million or 0% due to foreign currency translation), driven by performance in Europe where diesel is essential to meet fleet CO2 regulations targets coupled with light commercial vehicle sales on incumbent platforms.

Commercial vehicle sales increased by $9 million or 2% (including an unfavorable impact of $8 million or 1% due to foreign currency translation), primarily driven by performance in North America and Europe on new product launches and combined with favorable global product mix dynamics.

Aftermarket sales improved by $14 million or 4%, primarily on strong demand in Europe and Asia Pacific related to favorable aftermarket conditions including the continued high demand for replacement parts. Recovery in China from the end of the Chinese government's zero COVID-19 policy as well as new product introductions and favorable pricing impact also contributed to the growth.

Cost of Goods Sold and Gross Profit

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Cost of goods sold	$	784		$	767		$	2,374		$	2,183
% change compared with prior period	2.2		%				8.7		%
Gross profit percentage	18.3		%	18.8		%	19.3		%	19.3		%

	Cost of Goods Sold			Gross Profit
	(Dollars in millions)
Cost of Goods Sold / Gross Profit for the three months ended September 30, 2022	$	767		$	178
Increase/(decrease) due to:
Volume	12			5
Product mix	5			(23)
Price, net of inflation pass-through	—			(5)
Productivity, net	(12)			12
Research & development	2			(2)
Foreign exchange rate impacts	10			11
Cost of Goods Sold / Gross Profit for the three months ended September 30, 2023	$	784	784	$	176

28

For the three months ended September 30, 2023, cost of goods sold increased by $17 million, primarily driven by higher sales volumes and an unfavorable product mix which contributed to increases of $12 million and $5 million, respectively. Cost of goods sold further increased by $2 million related to Research and development ("R&D") costs reflecting the continued commitment to investment in new technologies and $10 million from foreign currency impacts from transactional, translational and hedging effects. Our continued focus on productivity, net of labor inflation and repositioning costs, contributed to a decrease in cost of goods sold of $12 million.

Gross profit decreased by $2 million, mainly driven by $23 million of unfavorable product mix from the decline of high margin products, $5 million of pricing net of inflation recovery from customer pass-through agreements, and $2 million of higher R&D costs as discussed above. These decreases were partially offset by $12 million of higher productivity net of labor inflation and repositioning costs, coupled with higher sales volumes of $5 million. Furthermore, foreign currency impacts from transactional, translational and hedging effects also contributed to increases in gross profit of $11 million.

	Cost of Goods Sold			Gross Profit
	(Dollars in millions)
Cost of Goods Sold / Gross Profit for the nine months ended September 30, 2022	$	2,183		$	522
Increase/(decrease) due to:
Volume	162			69
Product mix	40			(46)
Inflation pass-through, net of price	—			46
Commodity, transportation & energy inflation	42			(42)
Productivity, net	(29)			27
Research & development	12			(12)
Foreign exchange rate impacts	(36)			3
Cost of Goods Sold / Gross Profit for the nine months ended September 30, 2023	$	2,374	2374	$	567

For the nine months ended September 30, 2023, cost of goods sold increased by $191 million, primarily driven by our higher sales volumes and unfavorable product mix which contributed to increases of $162 million and $40 million, respectively. Cost of goods sold further increased $42 million from inflation of commodities, energy and transportation and $12 million from increased R&D costs which reflects the continued investment in new technologies and headcount year-over-year. Our focus on productivity, net of labor inflation, one-time expenses and higher repositioning costs, contributed to a decrease in cost of goods sold of $29 million. Foreign currency impacts from transactional, translational and hedging effects reduced cost of goods sold by $36 million.

Gross profit increased by $45 million, mainly driven by the higher sales volumes of $69 million and $46 million of inflation recovery from customer pass-through agreements net of pricing reductions. Furthermore, gross profit increased $27 million from higher productivity net of labor inflation, one-time expenses and higher repositioning costs as discussed above, and $3 million from foreign currency impacts from transactional, translational and hedging effects. These increases were partially offset by $42 million inflation on commodities, energy costs and transportation, as discussed above, $46 million of unfavorable product mix and a $12 million increase in R&D costs.

Selling, General and Administrative Expenses

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Selling, general and administrative expense	$	59		$	57		$	178		$	164
% of sales	6.1		%	6.0		%	6.1		%	6.1		%

Selling, general and administrative (“SG&A”) expenses for the three months ended September 30, 2023 increased by $2 million compared with the prior year primarily driven by a $2 million increase in legal and advisory fees following the completion of our Transaction and $1 million of labor inflation impact.

29

SG&A expenses for the nine months ended September 30, 2023 increased by $14 million compared with the prior year, primarily driven by $9 million of legal and advisory fees related to our Transaction, $4 million of labor inflation impact, and $3 million of higher incentive compensation expense.

Interest Expense

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Interest expense	$	50	$	18	$	108	$	61

For the three months ended September 30, 2023, interest expense increased by $32 million compared to the prior year due to $25 million of higher interest expense driven by the new 2023 Dollar Term Facility and increased interest rates, and $10 million of debt issuance cost amortization primarily due to the $200 million early repayment on our 2023 Dollar Term Facility, partially offset by $3 million from unrealized marked-to-market gains on our interest rate swaps.

For the nine months ended September 30, 2023, interest expense increased by $47 million compared to prior year due to $55 million of higher interest expense driven by the new 2023 Dollar Term Facility and increased interest rates, and $11 million of debt issuance cost amortization mainly due to the $200 million early repayment on our 2023 Dollar Term Facility. These increases in interest expense were partially offset by $10 million of interest accretion in the prior year on our Series B Preferred Stock that was fully redeemed in June 2022 and $7 million decrease in unrealized marked-to-market losses on our interest rate swaps.

Non-operating income

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Non-operating income	$	(4)	$	(29)	$	(1)	$	(73)

For the three months ended September 30, 2023, non-operating income amounted to $4 million versus $29 million in the prior year, due to a decrease of $23 million of interest income recognized in the prior year from unrealized marked-to-market gains on our interest rate swaps.

For the nine months ended September 30, 2023, non-operating income amounted to $1 million, versus $73 million in the prior year period, driven by a decrease of $56 million of interest income net of unrealized marked-to-market losses on our interest rate swaps, a $13 million loss on the remeasurement of the Series A Preferred Stock Agreement related to our capital structure transformation during the three months ended June 30, 2023, and $4 million of lower benefits from non-service components of pension cost compared to the prior year period.

Tax Expense

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Tax expense	$	13		$	26		$	70		$	83
Effective tax rate	18.6		%	19.8		%	25.1		%	23.0		%

The effective tax rate for the three months ended September 30, 2023 is lower than the effective rate for the three month ended September 30, 2022 primarily related to an increase in global R&D benefits, lower taxes on non-U.S. earnings partially offset by nondeductible expenses and prior year non-recurring decrease in withholding taxes on undistributed earnings.

The effective tax rate for the nine months ended September 30, 2023 is higher than the effective rate for the nine months ended September 30, 2022 primarily related to prior year non-recurring decrease in withholding taxes on undistributed earnings and nondeductible expenses in the prior year partially offset by increase in global research and development benefit and lower taxes on non-U.S. earnings.

30

In December 2022, the European Union reached an agreement to adopt the Minimum Tax Directive under Pillar Two. The agreement affirms that all Member States must transpose the Directive by December 31, 2023. The rules will therefore first be applicable for fiscal years starting on or after December 31, 2023. We will continue to monitor the implementation of Pillar Two in the countries in which we operate, as it is possible that such changes could materially impact our effective tax rate, corporate tax liabilities and cash tax liabilities.

The effective tax rate can vary from quarter to quarter due to changes in the Company’s global mix of earnings, the resolution of income tax audits, changes in tax laws, deductions related to employee share-based payments, internal restructurings, and pension mark-to-market adjustments.

Net Income

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Net income	$	57		$	105		$	209		$	278
Net income margin	5.9		%	11.1		%	7.1		%	10.3		%

Net income for the three months ended September 30, 2023 decreased by $48 million compared with the prior year, primarily due to $32 million of higher interest expense as discussed above and $25 million of lower non-operating income, partially offset by $13 million of lower tax expense.

Net income for the nine months ended September 30, 2023 decreased by $69 million compared with the prior year, primarily due to $72 million of lower non-operating income as discussed above, $47 million of higher interest expense and $14 million higher SG&A expenses, partially offset by a $45 million increase in gross profit, $13 million lower tax expense and a $5 million loss on extinguishment of debt recorded in the prior year.

Non-GAAP Measures

It is management’s intent to provide non-GAAP financial information to supplement the understanding of our business operations and performance, and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure is presented along with the most directly comparable GAAP measure so as not to imply that more emphasis should be placed on the non-GAAP measure. The non-GAAP financial information presented may be determined or calculated differently by other companies and may not be comparable to other similarly titled measures used by other companies. Additionally, the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for an analysis of the Company’s operating results as reported under GAAP.

31

EBITDA and Adjusted EBITDA (1)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Net income (GAAP)	$	57	$	105	$	209	$	278
Interest expense, net of interest income	47		(9)		98		(5)
Tax expense	13		26		70		83
Depreciation	23		21		66		64
EBITDA (Non-GAAP)	140		143		443		420
Reorganization items, net (2)	—		—		—		2
Stock compensation expense (3)	4		3		12		8
Repositioning costs (4)	6		1		14		4
Loss on extinguishment of debt	—		—		—		5
Discounting costs on factoring	1		1		3		2
Other non-operating income (5)	(1)		(2)		(4)		(11)
Capital structure transformation expenses (6)	2		—		22		—
Adjusted EBITDA (Non-GAAP)	$	152	$	146	$	490	$	430

(1)We evaluate performance on the basis of EBITDA and Adjusted EBITDA. We define “EBITDA” as our net income calculated in accordance with U.S. GAAP, plus the sum of net interest expense, tax expense and depreciation. We define “Adjusted EBITDA” as EBITDA, plus the sum of net reorganization items, stock compensation expense, repositioning costs, loss on extinguishment of debt, discounting costs on factoring, other non-operating income and capital structure transformation expenses. We believe that EBITDA and Adjusted EBITDA are important indicators of operating performance and provide useful information for investors because:

•EBITDA and Adjusted EBITDA exclude the effects of income taxes, as well as the effects of financing and investing activities by eliminating the effects of interest and depreciation expenses and therefore more closely measure our operational performance; and

•certain adjustment items, while periodically affecting our results, may vary significantly from period to period and have disproportionate effect in a given period, which affects the comparability of our results.

In addition, our management may use Adjusted EBITDA in setting performance incentive targets to align performance measurement with operational performance.

(2)The Company applied ASC 852 for periods subsequent to September 20, 2020, the date the Company and certain of its subsidiaries each filed a voluntary petition for relief under Chapter 11 of title 11 of the United States Code, to distinguish transactions and events that were directly associated with the Company’s reorganization from the ongoing operations of the business. Accordingly, certain expenses and gains incurred related to these transactions and events were recorded within Reorganization items, net in the Consolidated Interim Statements of Operations.

(3)Stock compensation expense includes only non-cash expenses.

(4)Repositioning costs includes severance costs related to restructuring projects to improve future productivity.

(5)Reflects the non-service component of net periodic pension costs and other income that are non-recurring or not considered directly related to the Company's operations.

(6)Includes the loss on remeasurement of the Agreements as well as third-party legal and advisory fees that are directly attributable to the Transaction.

32

Adjusted EBITDA for the Three Months Ended September 30, 2023

For the three months ended September 30, 2023, net income decreased by $48 million versus the prior year as discussed above within the Results of Operations for Three and Nine Months Ended September 30, 2023 section.

Adjusted EBITDA increased by $6 million compared to the prior year, mainly due to increased volume and productivity, and favorable foreign exchange impacts. These increases in Adjusted EBITDA were partially offset by unfavorable product mix and pricing net of inflation pass-through.

During the three months ended September 30, 2023, we saw product ramp-ups of new small engine applications in gasoline, offset by demand softening in diesel and commercial vehicle applications influenced by global macro economic dynamics which resulted in an unfavorable product mix.

The increased productivity combined with fixed cost savings was partially offset by year-over-year labor inflation.

R&D expenses increased $2 million which reflects continued investments in new technologies, increased hiring to accelerate growth in the new technologies and year-over-year labor inflation.

Gains in foreign currency from translational, transactional and hedging effects in the three months ended September 30, 2023, primarily driven by a higher Euro-to-US dollar exchange rate versus the prior-year period, also accounted for an $8 million increase in Adjusted EBITDA.

Adjusted EBITDA for the Nine Months Ended September 30, 2023

33

For the nine months ended September 30, 2023, net income decreased by $69 million versus the prior year as discussed above within the Results of Operations for the Three and Nine Months Ended September 30, 2023 section.

Adjusted EBITDA increased by $60 million compared to the prior year, mainly driven by increased volume and productivity, inflation pass-through net of pricing, and favorable foreign exchange impacts. These increases in Adjusted EBITDA were partially offset by inflation on commodities, energy and transportation and unfavorable product mix.

During the nine months ended September 30, 2023, we saw customer demand increases across all product lines, in a less disruptive supply chain environment, as the industry recovered from the semiconductor shortages experienced in the prior year. Favorable impact from new product launches in gasoline, volume ramp-ups in commercial vehicles, and favorable aftermarket conditions including high demand for replacement parts, also contributed to Adjusted EBITDA during the period.

We maintained our focus on productivity in the current year as rising commodity prices led to higher raw material costs, particularly for nickel, aluminum and steel alloys. We recovered a majority of the increases from our customer pass-through agreements, especially for nickel, and continue to negotiate with our customers for further pass-through while actively managing our supply base and cost recovery mechanisms to minimize the impact of materials cost inflation. The increased productivity was partially offset by year-over-year labor inflation and increases in our SG&A expenses from higher incentive compensation expense.

R&D expenses increased $12 million reflecting continued investment in new technologies, including hiring, and year-over-year labor inflation.

Gains in foreign currency from translational, transactional and hedging effects in the nine months ended September 30, 2023, primarily driven by lower Euro-to-US dollar exchange rates, also accounted for a $6 million increase in Adjusted EBITDA.

Liquidity and Capital Resources

We employ several means to manage our liquidity, and our sources of financing include cash flows from operations, cash and cash equivalents, our Term Loan Facilities, and Revolving Facility.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Cash and cash equivalents	$	162	$	246
Restricted cash	1		2
Revolving Facility - available borrowing capacity	570		475
Revolving Facility - borrowings or letters of credit outstanding	—		—
Term Loan Facilities - principal outstanding	1,677		1,186
Bilateral letter of credit facility - available capacity	3		1
Bilateral letter of credit facility - utilized capacity	12		14

On April 27, 2023, the Company entered into the Third Amendment to the Credit Agreement, which provided for additional financing of $700 million through the 2023 Dollar Term Facility and an increase of $95 million in maximum borrowings available under the Revolving Facility. The proceeds from the 2023 Dollar Term Facility were primarily used to finance the repurchase of shares of Series A Preferred Stock from the C&O Investors as part of the Transaction, and pay fees and expenses incurred in connection with the Third Amendment. The 2023 Dollar Term Facility matures on April 30, 2028. Prior to maturity, the 2023 Dollar Term Facility will be repaid quarterly in an amount equal to, during the first two years occurring after the Closing Date, 7.50% per annum of the aggregate principal amount, and thereafter, 10.00% per annum. During the nine months ended September 30, 2023, we repaid $200 million on our 2023 Dollar Term Facility and $5 million on our 2021 Dollar Term Facility.

As previously disclosed, the Company entered into the Agreements with the C&O Investors to repurchase certain shares and convert all remaining Series A Preferred Stock. As part of the Transaction, all holders of Series A Preferred Stock, including the C&O Investors, received an amount equal to the Accumulated Dividends and Additional Amounts outstanding at repurchase or conversion date (each as defined in Note 15, Series A Preferred Stock of the Notes to the

34

Consolidated Interim Financial Statements). As of September 30, 2023, all Series A Preferred Stock had either been repurchased or converted and there are no accumulated unpaid dividends on the Series A Preferred Stock. Refer to Note 15, Series A Preferred Stock of the Notes to the Consolidated Interim Financial Statements for further details regarding the Transaction.

We expect to continue investing in our facilities as we expand our manufacturing capacity for new product launches and invest in new technologies and strategic growth opportunities, in particular in the electrification of drivetrains. We believe the combination of expected cash flows, the term loan borrowings, and the Revolving Facility being committed until 2028, will provide us with adequate liquidity to support the Company's operations.

Share Repurchase Program

On November 16, 2021, the Board of Directors authorized a $100 million share repurchase program for one year, providing for the purchase of shares of Series A Preferred Stock and Common Stock. On November 2, 2022, the Board of Directors authorized the extension of the share repurchase program to November 15, 2023. On April 12, 2023, the Board of Directors further authorized an increase in the size of the share repurchase program to an aggregate amount of $250 million available as of that date.

As of September 30, 2023, the Company had repurchased $178 million of Common Stock, with $72 million remaining under the share repurchase program. For more information, see Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Cash Flow Summary for the Nine Months Ended September 30, 2023

	Nine Months Ended September 30,
	2023		2022
	(Dollars in millions)
Cash provided by (used for):
Operating activities	$	330	$	238
Investing activities	(48)		(78)
Financing activities	(366)		(436)
Effect of exchange rate changes on cash and restricted cash	(1)		(27)
Net decrease in cash, cash equivalents and restricted cash	$	(85)	$	(303)

Cash provided by operating activities increased by $92 million for the nine months ended September 30, 2023 versus the prior year. The increase was primarily driven by an increase of $49 million in net income, excluding the effects of non-cash items. Favorable impacts from working capital and other assets and liabilities of $17 million and $26 million, respectively, also contributed to the increase in cash provided by operating activities.

Cash used for investing activities decreased by $30 million for the nine months ended September 30, 2023 versus the prior year due to $21 million of decreased expenditures for property, plant and equipment and $9 million of cash settlement received on the re-couponing of our cross currency swap contracts which have been designated as net investment hedges of our Euro-denominated operations.

Cash used for financing activities decreased by $70 million for the nine months ended September 30, 2023 compared with the prior year. Cash flows for financing activities during the nine months ended September 30, 2023 included $667 million from the 2023 Dollar Term Facility net of debt financing costs. We paid an aggregate amount of $605 million to holders of the Series A Preferred Stock related to the Transaction, including the conversion of the Series A Preferred Stock as discussed above and in Note 15, Series A Preferred Stock of the Notes to the Consolidated Interim Financial Statements. We also made payments of $178 million for the repurchase of Common Stock under our share repurchase program and debt repayments of $205 million including a $200 million early debt repayment of our 2023 Dollar Term Facility and quarterly payments for our 2021 Dollar Term Facility. In comparison, cash used for financing activities for the nine months ended September 30, 2022 was primarily related to the Company's payment of $381 million for the final early redemption of our Series B Preferred Stock (exclusive of $28 million attributable to interest and included in cash from operating activities).

35

Off-Balance Sheet Arrangements

We do not engage in any off-balance sheet financial arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

The preparation of our Consolidated Interim Financial Statements in accordance with generally accepted accounting principles is based on the selection and application of accounting policies that require us to make significant estimates and assumptions about the effects of matters that are inherently uncertain. Actual results could differ from our estimates and assumptions, and any such differences could be material to our financial statements. Our critical accounting policies are summarized in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our 2022 Form 10-K.

Recent Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies of the Notes to the Consolidated Interim Financial Statements for further discussion of recent accounting pronouncements.

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including without limitation statements regarding the following, are forward-looking statements: statements regarding our future results of operations and financial position, results of operations and financial position, expectations regarding the growth of the turbocharger and electric vehicle markets and other industry trends, the sufficiency of our cash and cash equivalents, anticipated sources and uses of cash, anticipated investments in our business, our business strategy, pending litigation, anticipated interest expense, and the plans and objectives of management for future operations and capital expenditures are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including:

•increases in the costs and availability of raw materials, components, energy and transportation and our ability to offset inflation;

•sales to major customers as well as a network of independent dealers to manage the distribution of our products, and we could be adversely impacted by the loss of any of our such major customers or dealers, changes in their requirements for our products or changes in their financial condition.

•the negotiating positions of our customers and our ability to negotiate favorable pricing terms;

•risks associated with changes in the automotive industry and our inability, or a perception that we are unable, to respond appropriately to such changes, our financial condition and results of operations could be adversely impacted;

•risks associated with any program launch difficulties and inaccuracies in estimates of volumes of awarded business;

36

•changes in the automotive industry and economic or competitive conditions;

•risks related to economic, political, regulatory and foreign exchange;

•geopolitical conditions, such as the ongoing conflict between Russia and Ukraine, and catastrophic events, such as the COVID-19 pandemic;

•risks related to international operations and our investment in foreign markets;

•risks of increased scrutiny from customers, investors, regulators and others regarding sustainability/ESG practices, as well as the climate-related risks we may face, each of which could expose us to liabilities, including reputational harm, impact demand for our products, lead to increased costs and have other adverse effects on our business, supply chain and results of operations;

•risks associated with joint venture partnerships and joint development projects;

•any failure to protect our intellectual property or allegations that we have infringed the intellectual property of others; and our ability to license necessary intellectual property from third parties;

•work stoppages, other disruptions or the need to relocate any of our facilities;

•inability to recruit and retain qualified personnel;

•any failure to increase productivity or successfully execute repositioning projects or manage our workforce;

•potential material losses and costs as a result of any warranty claims and product liability actions brought against us;

•the commencement of any lawsuits, investigations and disputes arising out of our current and historical businesses, and the consequences thereof;

•potential material environmental liabilities and hazards;

•risks of changes in the effective tax rates

•the effects of any deterioration on industry, economic or financial conditions on our ability to access the capital markets on favorable terms;

•quality control and creditworthiness of the suppliers on which we rely;

•risks for system or service failures, including cyber or other security incidents, each of which could disrupt business operations, result in loss of critical and confidential information and adversely impact our reputation and results of operations; and

•the other factors described under the caption “Risk Factors” in our 2022 Form 10-K, as updated in this Quarterly Report on Form 10-Q, and our other filings with the SEC.

You should read this Quarterly Report on Form 10-Q and the documents that we reference herein completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of September 30, 2023, the net fair value of all financial instruments with exposure to currency risk was a $77 million asset. The potential loss or gain in fair value for such financial instruments from a hypothetical 10% adverse or favorable change in quoted currency exchange rates would be $141 million and $(150) million, respectively, at September 30, 2023 exchange rates. The model assumes a parallel shift in currency exchange rates; however, currency

37

exchange rates rarely move in the same direction. The assumption that currency exchange rates change in a parallel fashion may overstate the impact of changing currency exchange rates on assets and liabilities denominated in currencies other than the U.S. dollar.

There have been no other material changes to the Company’s quantitative and qualitative disclosures about interest rate or commodity price risks as disclosed in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risks, in our 2022 Form 10-K.

Item 4. Controls and Procedures

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based on management’s evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2023.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

38

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

We are involved in various lawsuits, claims and proceedings incident to the operation of our businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to us, we do not currently believe that such lawsuits, claims or proceedings will have a material adverse effect on our financial position, results of operations or cash flows. We accrue for potential liabilities in a manner consistent with accounting principles generally accepted in the United States. Accordingly, we accrue for a liability when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable.

For additional information regarding our legal proceedings, see Note 20, Commitments and Contingencies of the Notes to the Consolidated Interim Financial Statements.

Item 1A. Risk Factors

There have been no material changes to the risks described under "Risk Factors” in our 2022 Form 10-K. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed under “Risk Factors” in our 2022 Form 10-K. These factors could materially adversely affect our business, financial condition, or results of operations, and could cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements contained in this report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On November 16, 2021, the Board of Directors authorized a $100 million share repurchase program for one year, providing for the purchase of shares of Series A Preferred Stock and Common Stock. On November 2, 2022, the Board of Directors extended the duration of the share repurchase program to November 15, 2023. On April 12, 2023, the Board of Directors authorized a further increase in the size of the share repurchase program to an aggregate amount of $250 million as of that date.

The following table summarizes our share repurchase activity for the three months ended September 30, 2023 and additional information regarding our share repurchase program:

Period	Total Number of Common Shares Purchased	Average Price Paid per Share		Total Number of Preferred Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plan or Program	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan or Program
July 1, 2023 - July 31, 2023	9,001,214	$	7.44	—	$	—	9,001,214	$	166,403,263
August 1, 2023 - August 31, 2023	12,000,000	7.70		—	—		12,000,000	74,003,263
September 1, 2023 - September 30, 2023	235,695	7.70		—	—		235,695	72,189,441
Total	21,236,909	$	7.59	—	$	—	21,236,909	$	72,189,441

Other than the repurchases reflected in the table above, there were no purchases of equity securities by the issuer or affiliated purchasers during the quarter ended September 30, 2023.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

39

Not applicable.

Item 5. Other Information

Trading Agreements

During the three months ended June 30, 2023, no director or Section 16 officer of the Company adopted or terminated a "Rule 10b5-1 trading agreement" or "non-Rule 10b5-1 trading agreement," as each term is defined in Item 408(a) of Regulation S-K

40

Item 6. Exhibits

		Incorporated by Reference
Exhibit Number	Description	Form	File No.	Exhibit	Filing Date	Filed/ Furnished Herewith
3.1	Second Amended and Restated Certificate of Incorporation of Garrett Motion Inc., dated April 30, 2021	8-K	001-38636	3.1	04/30/2021
3.2	Amended and Restated Certificate of Designations of Series A Cumulative Convertible Preferred Stock of Garrett Motion Inc.	DEF14C	001-38636	Appendix B-1	05/15/2023
31.1	Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					*
31.2	Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					*
32.1	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					**
32.2	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					**
101.INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document					*
101.SCH	Inline XBRL Taxonomy Extension Schema Document					*
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document					*
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document					*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document					*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)					*

* Filed herewith.

**	Furnished herewith.
†	Management contract or compensatory plan or arrangement.

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Garrett Motion Inc.
Date: October 24, 2023	By:	/s/ Olivier Rabiller
		Olivier Rabiller
		President and Chief Executive Officer
Date: October 24, 2023	By:	/s/ Sean Deason
		Sean Deason
		Senior Vice President and Chief Financial Officer

42

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Olivier Rabiller, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 24, 2023	By:	/s/ Olivier Rabiller
		Olivier Rabiller
		President and Chief Executive Officer
		(principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Sean Deason, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of Garrett Motion Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 24, 2023	By:	/s/ Sean Deason
		Sean Deason
		Senior Vice President and Chief Financial Officer
		(principal financial officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 24, 2023	By:	/s/ Olivier Rabiller
		Olivier Rabiller
		President and Chief Executive Officer (principal executive officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Garrett Motion Inc. (the “Company”) for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 24, 2023	By:	/s/ Sean Deason
		Sean Deason
		Senior Vice President and Chief Financial Officer (principal financial officer)

XML

Cover - shares	9 Months Ended
	Sep. 30, 2023	Oct. 18, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-38636
Entity Registrant Name	Garrett Motion Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4873189
Entity Address, Address Line One	La Pièce 16
Entity Address, City or Town	Rolle
Entity Address, Country	CH
Entity Address, Postal Zip Code	1180
City Area Code	41 21
Local Phone Number	695 30 00
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	GTX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		242,419,764
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001735707
Current Fiscal Year End Date	--12-31

XML

CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales (Note 3)	$ 960	$ 945	$ 2,941	$ 2,705
Cost of goods sold	784	767	2,374	2,183
Gross profit	176	178	567	522
Selling, general and administrative expenses	59	57	178	164
Other expense, net	1	1	3	2
Interest expense	50	18	108	61
Loss on extinguishment of debt	0	0	0	5
Non-operating income	(4)	(29)	(1)	(73)
Reorganization items, net	0	0	0	2
Income before taxes	70	131	279	361
Tax expense (Note 5)	13	26	70	83
Net income	57	105	209	278
Less: preferred stock dividends (Note 15)	0	(40)	(80)	(117)
Less: preferred stock deemed dividends (Note 15)	0	0	(232)	0
Net income (loss) available for distribution	$ 57	$ 65	$ (103)	$ 161
Earnings (loss) per common share
Earnings per common share, basic (in USD per share)	$ 0.23	$ 0.21	$ (0.73)	$ 0.52
Earnings per common share, diluted (in USD per share)	$ 0.23	$ 0.21	$ (0.73)	$ 0.52
Weighted average common shares outstanding
Weighted average common shares outstanding, basic (in shares)	250,888,716	64,820,887	141,745,701	64,834,298
Weighted average common shares outstanding, diluted (in shares)	252,381,719	65,250,287	141,745,701	65,118,021

XML

CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 57	$ 105	$ 209	$ 278
Foreign exchange translation adjustment	14	10	8	13
Changes in fair value of effective cash flow hedges, net of tax (Note 16)	(2)	9	(3)	26
Changes in fair value of net investment hedges, net of tax (Note 16)	20	45	18	87
Total other comprehensive income, net of tax	32	64	23	126
Comprehensive income	$ 89	$ 169	$ 232	$ 404

XML

CONSOLIDATED INTERIM BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 162	$ 246
Restricted cash	1	2
Accounts, notes and other receivables – net (Note 6)	860	803
Inventories – net (Note 8)	294	270
Other current assets	73	110
Total current assets	1,390	1,431
Investments and long-term receivables	32	30
Property, plant and equipment – net	437	470
Goodwill	193	193
Deferred income taxes	225	232
Other assets (Note 9)	255	281
Total assets	2,532	2,637
Current liabilities:
Accounts payable	1,066	1,048
Current maturities of long-term debt (Note 14)	7	7
Accrued liabilities (Note 11)	312	320
Total current liabilities	1,385	1,375
Long-term debt (Note 14)	1,622	1,148
Deferred income taxes	21	25
Other liabilities (Note 12)	196	205
Total liabilities	3,224	2,753
COMMITMENTS AND CONTINGENCIES (Note 20)
EQUITY (DEFICIT)
Common Stock, par value $0.001; 1,000,000,000 and 1,000,000,000 shares authorized, 243,305,848 and 64,943,238 issued and 243,011,280 and 64,832,609 outstanding as of September 30, 2023 and December 31, 2022, respectively	0	0
Additional paid–in capital	1,188	1,333
Retained deficit	(1,939)	(1,485)
Accumulated other comprehensive income (Note 17)	59	36
Total deficit	(692)	(116)
Total liabilities and deficit	2,532	2,637
Series A Cumulative Convertible Preferred Stock
EQUITY (DEFICIT)
Series A Preferred Stock, par value $0.001; zero and 245,089,671 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	$ 0	$ 0

XML

CONSOLIDATED INTERIM BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Common stock, par value (in USD per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares, issued (in shares)	243,305,848	64,943,238
Common stock, shares, outstanding (in shares)	243,011,280	64,832,609
Series A Cumulative Convertible Preferred Stock
Preferred stock, par value (in USD per share)	$ 0.001	$ 0.001
Preferred stock, shares issued (in shares)	0	245,089,671
Preferred stock, shares outstanding (in shares)	0	245,089,671

XML

CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 209	$ 278
Adjustments to reconcile net income to net cash provided by operating activities
Deferred income taxes	13	16
Depreciation	66	64
Amortization of deferred issuance costs	17	6
Interest payments, net of debt discount accretion	0	(19)
Loss on extinguishment of debt	0	5
Loss on remeasurement of forward purchase contract	13	0
Foreign exchange loss	0	4
Stock compensation expense	12	8
Pension expense	1	0
Change in fair value of derivatives	21	(54)
Other	7	2
Changes in assets and liabilities:
Accounts, notes and other receivables	(76)	(166)
Inventories	(30)	(80)
Other assets	2	13
Accounts payable	57	180
Accrued liabilities	26	(2)
Other liabilities	(8)	(17)
Net cash provided by operating activities	330	238
Cash flows from investing activities:
Expenditures for property, plant and equipment	(57)	(78)
Re-couponing of cross-currency swap contract	9	0
Net cash used for investing activities	(48)	(78)
Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of debt financing costs	667	0
Payments of long-term debt	(205)	(5)
Redemption of Series B Preferred Stock	0	(381)
Repurchases of Series A Preferred Stock	(580)	(4)
Repurchases of Common Stock	(178)	0
Payments of Additional Amounts for conversion of Series A Preferred Stock	(25)	0
Payments for preference dividends	(42)	(42)
Payments for debt and revolving facility financing costs	(2)	(4)
Other	(1)	0
Net cash used for financing activities	(366)	(436)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	(1)	(27)
Net decrease in cash, cash equivalents and restricted cash	(85)	(303)
Cash, cash equivalents and restricted cash at beginning of the period	248	464
Cash, cash equivalents and restricted cash at end of the period	163	161
Supplemental cash flow disclosure:
Income taxes paid (net of refunds)	38	38
Interest paid	$ 45	$ 56

XML

CONSOLIDATED INTERIM STATEMENTS OF EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Millions	Total	Series A Cumulative Convertible Preferred Stock	Common Stock	Series A Preferred Stock	Series A Preferred Stock Series A Cumulative Convertible Preferred Stock	Common Stock	Common Stock Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Series A Cumulative Convertible Preferred Stock	Retained Deficit	Retained Deficit Series A Cumulative Convertible Preferred Stock	Retained Deficit Common Stock	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021				246,000,000		64,000,000
Beginning balance at Dec. 31, 2021	$ (468)			$ 0		$ 0		$ 1,326		$ (1,790)			$ (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	88									88
Share repurchases		$ (2)							$ (1)		$ (1)
Other comprehensive income/loss , net of tax	23												23
Stock-based compensation	2							2
Ending balance (in shares) at Mar. 31, 2022				246,000,000		64,000,000
Ending balance at Mar. 31, 2022	(357)			$ 0		$ 0		1,327		(1,703)			19
Beginning balance (in shares) at Dec. 31, 2021				246,000,000		64,000,000
Beginning balance at Dec. 31, 2021	(468)			$ 0		$ 0		1,326		(1,790)			(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	278
Other comprehensive income/loss , net of tax	126
Ending balance (in shares) at Sep. 30, 2022				246,000,000		64,000,000
Ending balance at Sep. 30, 2022	(102)			$ 0		$ 0		1,331		(1,555)			122
Beginning balance (in shares) at Mar. 31, 2022				246,000,000		64,000,000
Beginning balance at Mar. 31, 2022	(357)			$ 0		$ 0		1,327		(1,703)			19
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	85									85
Share repurchases		(1)							(1)
Other comprehensive income/loss , net of tax	39												39
Stock-based compensation	3							3
Ending balance (in shares) at Jun. 30, 2022				246,000,000		64,000,000
Ending balance at Jun. 30, 2022	(231)			$ 0		$ 0		1,329		(1,618)			58
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	105									105
Other comprehensive income/loss , net of tax	64												64
Stock-based compensation	3							3
Ending balance (in shares) at Sep. 30, 2022				246,000,000		64,000,000
Ending balance at Sep. 30, 2022	(102)			$ 0		$ 0		1,331		(1,555)			122
Beginning balance (in shares) at Dec. 31, 2022				246,000,000		64,000,000
Beginning balance at Dec. 31, 2022	(116)			$ 0		$ 0		1,333		(1,485)			36
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	81									81
Other comprehensive income/loss , net of tax	(6)												(6)
Dividends	(42)									(42)
Stock-based compensation	3							3
Ending balance (in shares) at Mar. 31, 2023				246,000,000		64,000,000
Ending balance at Mar. 31, 2023	(80)			$ 0		$ 0		1,336		(1,446)			30
Beginning balance (in shares) at Dec. 31, 2022				246,000,000		64,000,000
Beginning balance at Dec. 31, 2022	(116)			$ 0		$ 0		1,333		(1,485)			36
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	209
Other comprehensive income/loss , net of tax	23
Ending balance (in shares) at Sep. 30, 2023				0		243,000,000
Ending balance at Sep. 30, 2023	(692)			$ 0		$ 0		1,188		(1,939)			59
Beginning balance (in shares) at Mar. 31, 2023				246,000,000		64,000,000
Beginning balance at Mar. 31, 2023	(80)			$ 0		$ 0		1,336		(1,446)			30
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	71									71
Stock repurchased during period, (in shares)					(70,000,000)		(2,000,000)
Share repurchases		(567)	$ (18)						(366)		$ (201)	$ (18)
Excise tax on share repurchases	(6)									(6)
Other comprehensive income/loss , net of tax	(3)												(3)
Issuance of common stock for preference dividends (in shares)						26,000,000
Issuance of Common Stock for preference dividends	0							209		(209)
Conversion of Series A Preferred Stock to Common Stock (in shares)				(176,000,000)		(176,000,000)
Conversion of Series A Preferred Stock to Common Stock	(25)									(25)
Stock-based compensation	5							5
Ending balance (in shares) at Jun. 30, 2023				0		264,000,000
Ending balance at Jun. 30, 2023	(623)			$ 0		$ 0		1,184		(1,834)			27
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	57									57
Stock repurchased during period, (in shares)							(21,000,000)
Share repurchases		$ (1)	$ (161)						$ (1)	(161)
Excise tax on share repurchases	(1)									(1)
Other comprehensive income/loss , net of tax	32												32
Dividends	(42)									(42)
Stock-based compensation	4							4
Ending balance (in shares) at Sep. 30, 2023				0		243,000,000
Ending balance at Sep. 30, 2023	$ (692)			$ 0		$ 0		$ 1,188		$ (1,939)			$ 59

XML

Background and Basis of Presentation

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Background and Basis of Presentation

Note 1. Background and Basis of Presentation

Background

Garrett Motion Inc., (the “Company” or “Garrett”) designs, manufactures and sells highly engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (“OEMs”) and the global vehicle independent aftermarket, as well as automotive software solutions. These OEMs in turn ship to consumers globally. We are a global technology leader with significant expertise in delivering products across gasoline, diesel, natural gas and electric (hybrid and fuel cell) power trains. These products are key enablers for fuel economy and emission standards compliance.

Basis of Presentation

The accompanying unaudited Consolidated Interim Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by United States generally accepted accounting principles (“GAAP”) for complete financial statements. The unaudited Consolidated Interim Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and accompanying notes for the year ended December 31, 2022 included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 14, 2023 (our “2022 Form 10-K”). The results of operations for the three and nine months ended September 30, 2023 and cash flows for the nine months ended September 30, 2023 should not necessarily be taken as indicative of the entire year. All amounts presented are in millions, except per share amounts.

We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday to minimize the potentially disruptive effects of quarterly closing on our business processes. For differences in actual closing dates that are material to year-over-year comparisons of quarterly or year-to-date results, such differences have been adjusted for the three months ended September 30, 2022. Our actual closing date for the three months ended September 30, 2022 was October 1, 2022. There was no difference in actual closing date for the three months ended September 30, 2023.

We evaluate segment reporting in accordance with ASC 280, Segment Reporting. We concluded that Garrett operates in a single operating segment and a single reportable segment based on the operating results available and evaluated regularly by the chief operating decision maker (“CODM”), which is our Chief Executive Officer, to make decisions about resource allocation and performance assessment. The CODM makes operational performance assessments and resource allocation decisions on a consolidated basis, inclusive of all of the Company’s products across channels and geographies.

The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods.

Capital Structure Transformation Transaction

On April 12, 2023, the Company entered into the Transaction (as defined in Note 15 below) to increase the attractiveness of the Company to investors, including simplifying the Company’s capital stock by converting all outstanding Series A Preferred Stock into a single class of Common Stock, subject to certain conditions.

In the Transaction, the Company repurchased and aggregate of 69,707,719 shares of Series A Preferred Stock from the C&O Investors (as defined below), and converted all remaining outstanding 175,337,712 shares of Series A Preferred Stock into an equivalent number of shares of Common Stock. The total amounts paid to holders of Series A Preferred Stock in connection with the Transaction included aggregate cash payments of $605 million and the issuance of an

additional 25,577,517 shares of Common Stock in settlement of accumulated and unpaid preference dividends on the Series A Preferred Stock through June 30, 2023. The Transaction was financed through a new Term Loan B for an aggregate principal amount of $700 million under the framework of the Company's existing credit agreement. See Note 15, Series A Preferred Stock.

The Company recorded the following amounts in the Consolidated Interim Financial Statements related to the repurchase and conversion of its Series A Preferred Stock:

	Movements for the Nine Months Ended
	September 30, 2023
Consolidated Interim Balance Sheet:	(Dollars in millions)
Cash and cash equivalents	$	(605)
Preferred stock, Common stock and Additional Paid-in capital	(157)
Retained earnings	(441)
	Nine Months Ended September 30, 2023
Consolidated Interim Statement of Operations:	(Dollars in millions)
Non-operating expenses	$	13

The Company also incurred $9 million of Transaction-related costs for the nine months ended September 30, 2023, primarily for legal and advisory services that are included in Selling, general and administrative expenses in the Consolidated Interim Statement of Operations. See Note 14, Long-term Debt and Credit Agreement for discussion on the new Term Loan B and Note 15, Series A Preferred Stock for further discussion of the Transaction.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

The accounting policies of the Company are set forth in Note 3 to the Consolidated Financial Statements for the year ended December 31, 2022 included in our 2022 Form 10-K.

Recently Adopted Accounting Pronouncements

In September 2022, the FASB issued ASU 2022-04, Disclosure of Supplier Finance Program Obligations (Topic 405-50): Disclosure of Supplier Finance Purchase Obligations. The amendment in this update requires companies to disclose key terms of supplier financing programs used in connection with the purchase of goods and services, along with information about their obligations under these programs including a rollforward of those obligations. The Company adopted the new guidance as of January 1, 2023. See Note 10, Supplier Financing for disclosure related to the Company's supplier financing program obligations.

XML

Revenue Recognition and Contracts with Customers

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Recognition and Contracts with Customers

Note 3. Revenue Recognition and Contracts with Customers

Disaggregated Revenue

Net sales by region (determined based on country of shipment) and channel are as follows:

	Three Months Ended September 30, 2023								Three Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	147	$	54	$	2	$	203	$	134	$	54	$	1	$	189
Europe	382		45		9		436		381		41		6		428
Asia	287		13		5		305		288		14		6		308
Other	9		6		1		16		14		6		—		20
	$	825	$	118	$	17	$	960	$	817	$	115	$	13	$	945
	Nine Months Ended September 30, 2023								Nine Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	412	$	150	$	4	$	566	$	354	$	159	$	2	$	515
Europe	1,265		136		26		1,427		1,181		117		21		1,319
Asia	846		38		12		896		765		34		18		817
Other	33		18		1		52		36		18		—		54
	$	2,556	$	342	$	43	$	2,941	$	2,336	$	328	$	41	$	2,705

Contract Balances

The following table summarizes our contract assets and liabilities balances:

	2023		2022
	(Dollars in millions)
Contract assets—January 1	$	46	$	63
Contract assets—September 30	44		51
Change in contract assets—(Decrease)/Increase	$	(2)	$	(12)
Contract liabilities—January 1	$	(8)	$	(5)
Contract liabilities—September 30	(12)		(9)
Change in contract liabilities—(Increase)/Decrease	$	(4)	$	(4)

XML

Research, Development & Engineering

9 Months Ended

Sep. 30, 2023

Research and Development [Abstract]

Research, Development & Engineering

Note 4. Research, Development & Engineering

Garrett conducts research, development and engineering (“RD&E”) activities, which consist primarily of the development of new products and product applications. RD&E costs are charged to expense as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Customer reimbursements are netted against gross RD&E expenditures as they are considered a recovery of cost. Such costs are included in Cost of goods sold as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Research and development costs	$	42	$	38	$	128	$	112
Engineering-related expenses, net of customer (reimbursements) (1)	(3)		4		(8)		13
	$	39	$	42	$	120	$	125

(1)    Engineering-related expenses include customer reimbursements of $10 million and $6 million for the three months ended September 30, 2023 and 2022, respectively, and $34 million and $15 million for the nine months ended September 30, 2023 and 2022, respectively.

XML

Income Taxes

9 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Note 5. Income Taxes

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Tax expense	$	13		$	26		$	70		$	83
Effective tax rate	18.6		%	19.8		%	25.1		%	23.0		%

The effective tax rate for the three months ended September 30, 2023 is lower than the effective rate for the three months ended September 30, 2022 primarily related to an increase in global research and development benefits, lower taxes on non-U.S. earnings partially offset by nondeductible expenses, and a prior year non-recurring decrease in withholding taxes on undistributed earnings.

The effective tax rate for the nine months ended September 30, 2023 is higher than the effective rate for the nine months ended September 30, 2022 primarily related to a prior year non-recurring decrease in withholding taxes on undistributed earnings and nondeductible expenses, partially offset by increase in global research and development benefit and lower taxes on non-U.S. earnings.

The effective tax rate for the three months ended September 30, 2023 was lower than the U.S. federal statutory rate of 21% primarily related to a decrease in the annual effective tax rate driven by lower taxes on international operations, partially offset by nondeductible transaction costs.

The effective tax rate for the nine months ended September 30, 2023 was higher than the U.S. federal statutory rate of 21% primarily related to nondeductible expenses and tax reserves, partially offset by lower taxes on non-U.S. earnings and global research and development benefits.

XML

Accounts, Notes and Other Receivables-Net

9 Months Ended

Sep. 30, 2023

Receivables [Abstract]

Accounts, Notes and Other Receivables-Net

Note 6. Accounts, Notes and Other Receivables—Net

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Trade receivables	$	667	$	619
Notes receivable	111		105
Other receivables	89		88
	867		812
Less—Allowance for expected credit losses	(7)		(9)
	$	860	$	803

Trade receivables include $44 million and $46 million of unbilled customer contract asset balances as of September 30, 2023 and December 31, 2022, respectively. These amounts are billed in accordance with the terms of customer contracts to which they relate. See Note 3, Revenue Recognition and Contracts with Customers.

Notes receivable is related to guaranteed bank notes without recourse that the Company receives in settlement of accounts receivables, primarily in the Asia Pacific region. See Note 7, Factoring and Notes Receivable for further information.

XML

Factoring and Notes Receivable

9 Months Ended

Sep. 30, 2023

Receivables [Abstract]

Factoring and Notes Receivable

Note 7. Factoring and Notes Receivable

The Company enters into arrangements with financial institutions to sell eligible trade receivables. The receivables are sold without recourse and the Company accounts for these arrangements as true sales. The Company also receives guaranteed bank notes without recourse, in settlement of accounts receivables, primarily in the Asia Pacific region. The Company can hold the bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash. Bank notes sold to third-party financial institutions without recourse are likewise accounted for as true sales.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Eligible receivables sold without recourse	$	184	$	112	$	584	$	481
Guaranteed bank notes sold without recourse	41		35		41		102

The expenses related to the sale of trade receivables and guaranteed bank notes are recognized within Other expense, net in the Consolidated Interim Statements of Operations. Such expenses amounted to $1 million and $3 million for the three and nine months ended September 30, 2023, respectively, and were immaterial for the three and nine months ended September 30, 2022.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Receivables sold but not yet collected by the bank from the customer	$	7	$	5
Guaranteed bank notes sold but not yet collected by the bank from the customer	—		—

As of September 30, 2023 and December 31, 2022, the Company had no guaranteed bank notes pledged as collateral.

XML

Inventories-Net

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Inventories-Net

Note 8. Inventories—Net

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Raw materials	$	197	$	203
Work in process	24		18
Finished products	110		80
	331		301
Less—Reserves	(37)		(31)
	$	294	$	270

XML

Other Assets

9 Months Ended

Sep. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets

Note 9. Other Assets

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Advanced discounts to customers, non-current	$	41	$	51
Operating right-of-use assets (Note 13)	40		44
Income tax receivable	22		22
Pension and other employee related	4		4
Designated cross-currency swaps	71		74
Designated and undesignated derivatives	66		76
Other	11		10
	$	255	$	281

XML

Supplier Financing

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Supplier Financing

Note 10. Supplier Financing

The Company has supplier financing arrangements with two third-party financial institutions under which certain suppliers may factor their receivables from Garrett. The Company also enters into arrangements with banking institutions to issue bankers acceptance drafts in settlement of accounts payables, primarily in the Asia Pacific region. The bankers acceptance drafts, or guaranteed bank notes, have a contractual maturity of six months or less, and may be held by suppliers until maturity, transferred to their suppliers, or discounted with financial institutions in exchange for cash. The supplier financing obligations and guaranteed bank notes outstanding are recorded within Accounts payable in our Consolidated Interim Balance Sheet.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Supplier financing obligations outstanding with financial institutions	$	67	$	33
Guaranteed bank notes outstanding	172		171

XML

Accrued Liabilities

9 Months Ended

Sep. 30, 2023

Accrued Liabilities, Current [Abstract]

Accrued Liabilities

Note 11. Accrued Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Customer pricing reserve	$	64	$	50
Compensation, benefit and other employee related	74		69
Repositioning	12		9
Product warranties and performance guarantees - short-term (Note 20)	17		18
Income and other taxes	55		39
Advanced discounts from suppliers, current	4		8
Customer advances and deferred income (1)	18		29
Accrued interest	25		13
Short-term lease liability (Note 13)	9		9
Accrued freight	13		9
Dividends payable	—		42
Designated and undesignated derivatives	8		8
Other (primarily operating expenses) (2)	13		17
	312		320

(1)Customer advances and deferred income include $12 million and $8 million of contract liabilities as of September 30, 2023 and December 31, 2022, respectively. See Note 3, Revenue Recognition and Contracts with Customers.

(2)Includes $3 million and $3 million of environmental liabilities as of September 30, 2023 and December 31, 2022, respectively.

The Company accrues repositioning costs related to projects to optimize its product costs and right-size our organizational structure. Expenses related to the repositioning accruals are included in Cost of goods sold and Selling, general and administrative expenses in our Consolidated Interim Statements of Operations.

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2022	$	9	$	—	$	9
Charges	13		2		15
Usage—cash	(10)		—		(10)
Non-cash asset write-offs	—		(2)		(2)
Balance at September 30, 2023	$	12	$	—	$	12

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2021	$	10	$	—	$	10
Charges	4		—		4
Usage—cash	(5)		—		(5)
Balance at September 30, 2022	$	9	$	—	$	9

XML

Other Liabilities

9 Months Ended

Sep. 30, 2023

Other Liabilities Disclosure [Abstract]

Other Liabilities

Note 12. Other Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Income taxes	$	104	$	99
Pension and other employee related	17		21
Long-term lease liability (Note 13)	33		36
Advanced discounts from suppliers	3		6
Product warranties and performance guarantees – long-term (Note 20)	9		10
Environmental remediation – long term	12		14
Long-term accounts payable	7		8
Other	11		11
	196		205

XML

Leases

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Leases

Note 13. Leases

We have operating leases that primarily consist of real estate, machinery and equipment. Our leases have remaining lease terms of up to 15 years, some of which include options to extend the leases for up to two years, and some of which include options to terminate the leases within the year.

The components of lease expense are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Operating lease cost	$	4	$	4	$	12	$	12

Supplemental cash flow information related to operating leases is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	3	$	3	$	10	$	9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	—		2		2		4

Supplemental balance sheet information related to operating leases is as follows:

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Other assets	$	40	$	44
Accrued liabilities	9		9
Other liabilities	33		36

	September 30, 2023		December 31, 2022
Weighted-average remaining lease term (in years)	8.14		8.41
Weighted-average discount rate	5.69	%	5.61	%

Maturities of operating lease liabilities as of September 30, 2023 were as follows:

	(Dollars in millions)
2023	$	3
2024	10
2025	8
2026	6
2027	5
Thereafter	20
Total lease payments	52
Less imputed interest	(11)
	$	41

XML

Long-term Debt and Credit Agreements

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Long-term Debt and Credit Agreements

Note 14. Long-term Debt and Credit Agreements

The principal outstanding and carrying amounts of our long-term debt as of September 30, 2023 and December 31, 2022 are as follows:

	Due	Interest Rate	September 30, 2023		December 31, 2022
2021 Dollar Term Facility	4/30/2028	SOFR plus 351 bps	$	700	$	706
2023 Dollar Term Facility	4/30/2028	SOFR plus 450 bps	500		—
Euro Term Facility	4/30/2028	EURIBOR plus 350 bps	477		480
Total principal outstanding			1,677		1,186
Less: unamortized deferred financing costs			(48)		(31)
Less: current portion of long-term debt			(7)		(7)
Total long-term debt			$	1,622	$	1,148

Credit Facilities

On April 30, 2021, the Company entered into a credit agreement (as amended from time to time, the "Credit Agreement") providing for senior secured financing, consisting of a seven-year secured first-lien U.S. Dollar term loan facility initially in the amount of $715 million (the “2021 Dollar Term Facility”), a seven-year secured first-lien Euro term loan facility initially in the amount of €450 million (the “Euro Term Facility”) and a five-year senior secured first-lien revolving credit facility initially in the amount of $300 million providing for multi-currency revolving loans (the “Revolving Facility”). The maximum amount of borrowings available under the Revolving Facility was increased to $475 million in 2022.

On April 27, 2023, the Company entered into Amendment No. 3 (the "Third Amendment") to the Credit Agreement, which provided for additional financing consisting of a five-year secured first-lien U.S. Dollar term loan facility initially in the amount of $700 million (the “2023 Dollar Term Facility”, together with the 2021 Dollar Term Facility and Euro Term Facility, the "Term Loan Facilities", and together with the Revolving Facility, the "Credit Facilities"). The full amount of the 2023 Dollar Term Facility was drawn on June 6, 2023 (the "Closing Date"), and the proceeds were primarily used to finance the repurchases of the Series A Preferred Stock as part of the Transaction, and pay fees and expenses incurred in connection with the Third Amendment.

The 2023 Dollar Term Facility will mature on April 30, 2028. Prior to maturity, the 2023 Dollar Term Facility will be repaid quarterly in an amount equal to, during the first two years occurring after the Closing Date, 7.50% per annum of the aggregate principal amount, and thereafter, 10.00% per annum. The Term Borrowers may also prepay the 2023 Dollar Term Facility at any time in whole or in part without premium or penalty, subject to certain exceptions (including for (i) customary breakage and redeployment costs in the case of prepayment of term benchmark rate loans and (ii) 2023 Dollar Term Facility repricing events occurring during the period from the Closing Date to the date that is twelve months following the Closing Date).

The Third Amendment also provided for (i) an increase in the maximum borrowing amount under the Revolving Facility by $95 million (the “Incremental Revolving Commitment”) to an aggregate amount of $570 million; and (ii) an extension of the maturity date for the Revolving Facility by two years from April 30, 2026 to April 30, 2028 (or January 30, 2028 if any of the currently outstanding term loans or term loans under the 2023 Dollar Term Facility maturing as of April 30, 2028 remain outstanding as of such date). The Incremental Revolving Commitment has the same terms and is generally subject to the same conditions applicable to the existing revolving facility under the Credit Agreement, except for fees paid in connection with the arrangement of the increased amount.

Under the Revolving Facility, the Company may use up to $125 million for the issuance of letters of credit to its subsidiaries. Letters of credit are available for issuance under the Credit Agreement on terms and conditions customary for financings of this kind, which issuances reduce availability under the Revolving Facility. As of September 30, 2023, the Company had no loans outstanding under the Revolving Facility, no outstanding letters of credit, and available borrowing capacity of approximately $570 million.

Separate from the Revolving Facility, the Company has a bilateral letter of credit facility in the amount of $15 million, which matures on April 30, 2026. As of September 30, 2023, the Company had $12 million utilized and $3 million of remaining available capacity under such facility.

Minimum scheduled principal repayments of the Credit Facilities as of September 30, 2023 are as follow:

	September 30, 2023
	(Dollars in millions)
2023	$	2
2024	7
2025	7
2026	17
2027	77
Thereafter	1,567
Total debt payments	$	1,677

Interest Rate and Fees

The 2021 Dollar Term Facility is subject to an interest rate, at our option, of either (a) an alternate base rate (“ABR”) (which shall not be less than 1.50%) or (b) an adjusted SOFR rate (“SOFR”) (which shall not be less than 0.50%), in each case, plus an applicable margin equal to 3.51% in the case of SOFR loans and 2.25% in the case of ABR loans. The Euro Term Facility is subject to an interest rate equal to an adjusted EURIBOR rate (which shall not be less than zero) plus an applicable margin equal to 3.50%. Interest payments with respect to the 2021 Dollar and Euro Term Facilities are required either on a quarterly basis (for ABR loans) or at the end of each interest period (for SOFR and EURIBOR loans) or, if the duration of the applicable interest period exceeds three months, then every three months.

The 2023 Dollar Term Facility will bear interest, at the Term Borrowers’ election, at a rate per annum equal to (i) SOFR (subject to a 0.50% floor) plus the applicable margin or (ii) the base rate plus the applicable margin. The applicable margin for loans under the 2023 Dollar Term Facility is 4.50% for SOFR loans and 3.50% for base rate loans.

The Revolving Facility is subject to an interest rate comprised of an applicable benchmark rate as provided under the Credit Agreement (which shall not be less than 1.00% if such benchmark is the ABR rate and not less than 0.00% in the case of other applicable benchmark rates) that is selected based on the currency in which borrowings are outstanding thereunder, in each case, plus an applicable margin, that may vary based on our leverage ratio.

In addition to paying interest on outstanding borrowings under the Revolving Facility, we are also required to pay a quarterly commitment fee based on the average daily unused portion of the Revolving Facility during such quarter, which is determined by our leverage ratio and ranges from 0.25% to 0.50% per annum.

Prepayments

The Credit Agreement contains certain mandatory prepayment provisions in the event that we incur certain types of indebtedness, receive net cash proceeds from certain non-ordinary course asset sales or other dispositions of property, or have excess cash flow (calculated on an annual basis with the required prepayment equal to 50%, 25% or 0% of such excess cash flow, subject to compliance with certain leverage ratios), in each case subject to terms and conditions customary for financings of this kind.

On July 31, 2023, the Company made an early repayment in the amount of $200 million on the 2023 Dollar Term Facility. The early repayment resulted in incremental amortization on debt issuance cost in the amount of $9 million, included within Interest Expense in the Consolidated Interim Statement of Operations.

Certain Covenants

The Credit Agreement contains certain affirmative and negative covenants customary for financings of this type. The Revolving Facility also contains a financial covenant requiring the maintenance of a consolidated total leverage ratio of not greater than 4.7 times as of the end of each fiscal quarter if, on the last day of any such fiscal quarter, the aggregate amount of loans and letters of credit (excluding backstopped or cash collateralized letters of credit and other letters of credit with an aggregate face amount not exceeding $30 million) outstanding under the Revolving Facility exceeds 35% of the aggregate commitments in effect thereunder on such date. As of September 30, 2023, the Company was in compliance with all covenants.

XML

Series A Preferred Stock

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Series A Preferred Stock

Note 15. Series A Preferred Stock

On April 12, 2023 (the “Transaction Date”), the Company entered into separate definitive agreements (the “Agreements”) with each of Centerbridge Partners, L.P. and funds managed by Oaktree Capital Management, L.P. (collectively, the “C&O Investors”) to effect a series of integrated transactions (collectively the “Transaction”) designed to increase the attractiveness of the Company to investors, including by simplifying the Company’s capital structure by converting all outstanding Series A Preferred Stock into a single class of Common Stock, subject to certain conditions.

As part of the Agreements, the holders of a majority of the outstanding shares of the Series A Preferred Stock authorized and approved the amendment and restatement of the certificate of designations for the Series A Preferred Stock (as amended, the “Certificate of Designations”) to, among other things, require the conversion of all shares of Series A Preferred Stock into shares of the Company’s common stock (the “2023 Conversion”), subject to the repurchase by the Company of a portion of the shares of Series A Preferred Stock held by the C&O Investors (the “Series A Repurchase”).

Under the terms of the Agreements, the Company agreed to repurchase a total of $570 million (“Base Repurchase Price”) of shares of Series A Preferred Stock from the C&O Investors at a cash price of $8.10 per share which was subsequently adjusted to equal the volume-weighted average price of the Common Stock for the fifteen trading days following the announcement of the transactions (the “15 Days VWAP”), subject to a minimum price of $7.875 per share and a maximum price of $8.50 per share. The 15 Days VWAP was subsequently established at a value of $8.177 per share.

As part of the Transaction, all holders of Series A Preferred Stock, including the C&O Investors, received approximately 0.104379 shares of Common Stock, being an amount equal to $0.853509 per share of Series A Preferred Stock, valued at the 15 Days VWAP, representing accumulated and unpaid preference dividends on each share of Series A Preferred Stock through June 30, 2023 (the “Accumulated Dividends”), as well as $0.144375 per share of Series A Preferred Stock, representing the preference dividends that would have accrued on the Series A Preferred Stock through September 30, 2023 (the “Additional Amounts”).

As part of the Transaction, following the effectiveness of the Certificate of Designations which occurred on June 6, 2023, the Company completed all steps of the Transaction as follows:

•The Company paid $580 million to the C&O Investors in connection with the repurchase of 69,707,719 shares of Series A Preferred Stock, comprising of the Base Repurchase Price as well as $10 million ($0.144375 for each repurchased share) in consideration of the Additional Amounts on the repurchased shares of Series A Preferred Stock.

•The remaining 175,337,712 shares of Series A Preferred Stock outstanding following such repurchase were converted into 175,337,712 shares of Common Stock (in accordance with the customary procedures of the Company’s transfer agent, for shares held in registered form, and of the Depository Trust Company, for shares held in street name). Following the completion of the 2023 Conversion, trading of the Series A Preferred Stock on Nasdaq was suspended;

•As part of the 2023 Conversion, the Company also paid $25 million ($0.144375 for each converted share) to the holders of Series A Preferred Stock in consideration of the Additional Amounts on the shares of Series A Preferred Stock that were converted; and

•Issued 25,577,517 shares of Common Stock to all holders of Series A Preferred Stock (equal to $0.853509 per share, valued at the 15 Days VWAP, adjusted to avoid the issuance of fractional shares of Common Stock), in consideration of the Accumulated Dividends of an aggregate amount of $209 million. Cash payments for fractional shares were immaterial.

The Agreements were accounted for as freestanding physically settled forward purchase contracts. The Agreements were initially recorded at fair value and then remeasured through earnings until the establishment of the 15 Days VWAP, whereupon the Agreements were subsequently measured based on the amount of consideration to be paid at settlement. A Monte-Carlo simulation model was used to determine the Transaction Date fair value of the Agreements by simulating a range of possible future stock prices for the Company through the expected settlement date of the Agreements. The significant assumptions utilized in estimating the fair value of the Agreements include: (i) a dividend yield of 0.0%; (ii) an expected volatility of 40.0%; (iii) a risk-free interest rate of 4.23% based on observed interest rates from the Treasury Constant Maturity yield curve consistent with the simulation term; and (iv) a starting share price of $8.25 based on the market price of the Company’s common stock as of the Transaction Date.

The initial fair value of the Agreements represented a forward purchase liability of $4 million. A loss of $13 million was recognized in Non-operating expense in the Consolidated Interim Statement of Operations to reflect the subsequent remeasurement of fair value of the Agreements due to changes in the market price of the Company’s Common Stock. The difference between the fair value of consideration transferred under the Agreements and the carrying value of the repurchased Series A Preferred Stock, amounting to $201 million, was recorded to Retained Deficit as a deemed dividend on the repurchase of shares of Series A Preferred Stock from the C&O Investors as part of the Transaction. A liability for excise tax, amounting to $6 million, was also recorded to Retained Deficit as a deemed dividend.

In connection with the 2023 Conversion, the Company also recognized a deemed dividend on the 2023 Conversion for $25 million, corresponding to the Additional Amounts paid to the holders of Series A Preferred Stock on the shares of Series A Preferred Stock that were converted.

As part of the Agreements, the C&O Investors have agreed with the Company to certain changes to their governance rights under the Company’s governance documents, including a reduction of their existing board nomination rights, as well as lock-up restrictions on their equity securities of the Company for up to twelve months, and certain limits on their ability to purchase additional equity securities of the Company and to voting limitations, in each case for a period of up to eighteen months.

On April 12, 2023, the Company also announced an increase in its share repurchase authorization to $250 million. Under the share repurchase program, the Company may repurchase shares of Common Stock in open market transactions, privately negotiated purchases and other transactions from time to time.

The following table summarizes the effects of the Transaction on the Consolidated Interim Balance Sheet as of September 30, 2023 and the Consolidated Interim Statement of Operations and Consolidated Interim Statement of Cash Flows for the nine months ended September 30, 2023:

	Series A Repurchase		2023 Conversion		Settlement of Accumulated Dividends		Excise tax on share repurchase		Total
	(Dollars in millions)
Consolidated Interim Balance Sheet - increase/(decrease):
Cash and cash equivalents	$	(580)	$	(25)	$	—	$	—	$	(605)
Accrued liabilities	—		—		—		6		6
Preferred Stock	—		—		—		—		—
Common Stock	—		—		—		—		—
Additional Paid-in capital	(366)		—		209		—		(157)
Retained earnings	(201)		(25)		(209)		(6)		(441)
Consolidated Interim Statement of Operations:
Non-operating expenses	13		—		—		—		13
Consolidated Interim Statement of Cash Flows
Repurchases of Series A Preferred Stock	(580)		—		—		—		(580)
Payments for Additional Amounts for conversion of Series A Preferred Stock	—		(25)		—		—		(25)

The Company has also incurred $9 million of Transaction-related costs for the nine months ended September 30, 2023, primarily for legal and advisory services that are included in Selling, general and administrative expenses in the Consolidated Interim Statement of Operations.

XML

Financial Instruments and Fair Value Measures

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments and Fair Value Measures

Note 16. Financial Instruments and Fair Value Measures

Our credit, market and foreign currency risk management policies are described in Note 19, Financial Instruments and Fair Value Measures, to the Consolidated Financial Statements for the year ended December 31, 2022 included in our 2022 Form 10-K. As of September 30, 2023 and December 31, 2022, we had contracts with aggregate gross notional amounts of $2,884 million and $2,621 million, respectively, to hedge interest rates and foreign currencies, principally the U.S. Dollar, Swiss Franc, British Pound, Euro, Chinese Yuan, Japanese Yen, Mexican Peso, New Romanian Leu, Czech Koruna, Australian Dollar and Korean Won.

Fair Value of Financial Instruments

The FASB’s accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). Financial and nonfinancial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2023 and December 31, 2022:

					Fair Value
	Notional Amounts				Assets					Liabilities
	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022			September 30, 2023		December 31, 2022
Designated instruments:
Designated forward currency exchange contracts	$	449	$	565	$	15	$	22	(a)	$	6	$	6	(c)
Designated cross-currency swaps	1,015		715		71		74		(b)	—		—
Designated interest-rate swaps	200		—		1		—		(b)	—		—
Total designated instruments	1,664		1,280		87		96			6		6
Undesignated instruments:
Undesignated interest rate swaps	879		1,024		65		76		(b)	—		—
Undesignated forward currency exchange contracts	341		317		3		4		(a)	2		2		(c)
Total undesignated instruments	1,220		1,341		68		80			2		2
Total designated and undesignated instruments	$	2,884	$	2,621	$	155	$	176		$	8	$	8

(a) Recorded within Other current assets

(b) Recorded within Other assets

(c) Recorded within Accrued liabilities

As of September 30, 2023, the Company had outstanding interest rate swaps with aggregate notional amounts of €830 million ($879 million based on September 30, 2023 foreign exchange rates) and $200 million, with maturities of April 2024, July 2024, October 2024, April 2025, April 2026, April 2027 and April 2028. The Company uses interest rate swaps specifically to mitigate variable interest risk exposure on its long-term debt portfolio. The $200 million interest rate swaps have been designated as cash flow hedges. The designated interest rate swaps' fair value were net assets of $1 million as of September 30, 2023.

The Company executed cross-currency swaps which have been designated as net investment hedges of its Euro-denominated operations and cash flow hedges to hedge the foreign currency exposure from foreign currency-denominated debt. In May 2023, the Company re-couponed the cross-currency swap contracts which have been designated as net investment hedges and received a cash settlement of $9 million. As of September 30, 2023, an aggregate notional amount of €615 million was designated as net investment hedges of the Company’s investment in Euro-denominated operations and €280 million was designated as cash flow hedges. The cross-currency swaps’ fair values were net assets of $71 million as of September 30, 2023. Our Consolidated Interim Statements of Comprehensive Income include Changes in fair value of net investment hedges and cash flow hedges, net of tax, of $20 million and $18 million, during the three and nine months ended September 30, 2023, respectively, related to these designated cross-currency swaps. No ineffectiveness has been recorded on the designated cross-currency hedges.

The Company's forward currency exchange contract under our cash flow hedging program are assessed as highly effective and are designated as cash flow hedges. Gains and losses on derivatives qualifying as cash flow hedges are recorded in Accumulated other comprehensive income until the underlying transactions are recognized in earnings.

The foreign currency exchange, interest rate swap and cross-currency swap contracts are valued using market observable inputs. As such, these derivative instruments are classified within Level 2. The assumptions used in measuring the fair value of the cross-currency swap are considered Level 2 inputs, which are based upon market-observable interest rate curves, cross-currency basis curves, credit default swap curves, and foreign exchange rates.

The carrying value of Cash, cash equivalents and restricted cash, Account receivables and Notes and Other receivables contained in the Consolidated Interim Balance Sheet approximates fair value.

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	September 30, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(Dollars in millions)
Term Loan Facilities	$	1,629	$	1,671	$	1,156	$	1,151

The Company determined the fair value of certain of its long-term debt and related current maturities utilizing transactions in the listed markets for similar liabilities. As such, the fair value of the long-term debt and related current maturities is considered Level 2.

XML

Accumulated Other Comprehensive Income

9 Months Ended

Sep. 30, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income

Note 17. Accumulated Other Comprehensive Income

The changes in Accumulated Other Comprehensive Income by component are set forth below:

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2022	$	(44)	$	13	$	85	$	(18)	$	36
Other comprehensive income before reclassifications	8		17		18		—		43
Amounts reclassified from accumulated other comprehensive income	—		(20)		—		—		(20)
Net current period other comprehensive income	8		(3)		18		—		23
Balance at September 30, 2023	$	(36)	$	10	$	103	$	(18)	$	59

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2021	$	(43)	$	7	$	41	$	(9)	$	(4)
Other comprehensive income before reclassifications	13		43		87		—		143
Amounts reclassified from accumulated other comprehensive income	—		(17)		—		—		(17)
Net current period other comprehensive income	13		26		87		—		126
Balance at September 30, 2022	$	(30)	$	33	$	128	$	(9)	$	122

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Earnings Per Share

Note 18. Earnings Per Share

For the three months ended September 30, 2023, basic earnings per share ("EPS") is computed using the weighted-average number of common shares outstanding during the period.

For the nine months ended September 30, 2023 as well as the three and nine months ended September 30, 2022, basic earnings per share is calculated using the two-class method as our Series A Preferred Stock, which was converted into Common Stock pursuant to the Transaction, was considered a participating security. The two-class method requires an allocation of earnings to all securities that participate in dividends with common shares, such as our Series A Preferred Stock, to the extent that each security may share in the entity’s earnings. Basic earnings per share are then calculated by dividing undistributed earnings allocated to common stock by the weighted average number of common shares outstanding for the period. The Series A Preferred Stock was not included in the computation of basic earnings per share in periods in which we have a net loss, as the Series A Preferred Stock was not contractually obligated to share in our net losses.

Diluted earnings per share for the three months ended September 30, 2023 is calculated based on the weighted-average number of common shares outstanding for the period plus the dilutive effect of common stock equivalents using the treasury stock method. Diluted earnings per share for the nine months ended September 30, 2023 as well as the three and nine months ended September 30, 2022 is calculated using the more dilutive of the two-class or if-converted methods. The two-class method uses net income available to common shareholders and assumes conversion of all potential shares other than the participating securities. The if-converted method uses net income and assumes conversion of all potential shares including the participating securities.

The details of the EPS calculations for the three and nine months ended September 30, 2023 and 2022 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions except per share)
Basic earnings per share:
Net income	$	57	$	105	$	209	$	278
Less: preferred stock dividend	—		(40)		(80)		(117)
Less: preferred stock deemed dividends	—		—		(232)		—
Net (loss) income available for distribution	57		65		(103)		161
Less: earnings allocated to participating securities	—		(51)		—		(127)
Net (loss) income available to common shareholders	$	57	$	14	$	(103)	$	34
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
EPS – Basic	$	0.23	$	0.21	$	(0.73)	$	0.52
Diluted earnings per share:
Method used:			Two-class		Two-class		Two-class
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
Dilutive effect of unvested RSUs and other contingently issuable shares	1,493,003		429,400		—		283,723
Weighted average common shares outstanding – Diluted	252,381,719		65,250,287		141,745,701		65,118,021
EPS – Diluted	$	0.23	$	0.21	$	(0.73)	$	0.52

For the periods where a net loss attributable to common shareholders is present, dilutive securities have been excluded from the calculation of diluted net loss per share attributable to common stockholders as including them would have been anti-dilutive. For the nine months ended September 30, 2023, the weighted-average number of unvested RSUs and other contingently issuable shares excluded from the computations was 1,349,442 shares.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Related Party Transactions

Note 19. Related Party Transactions

We lease certain facilities and receive property maintenance services from Honeywell International Inc. (“Honeywell”), which is a holder of our Common Stock and was also a holder of our Series A Preferred Stock prior to the 2023 Conversion as discussed below and in Note 15, Series A Preferred Stock. We also contract with Honeywell for the occasional purchase of certain goods and services. Lease and service agreements were made at commercial terms prevalent in the market at the time they were executed. Honeywell is not considered a related party subsequent to the 2023 Conversion.

Our payments under the agreements with Honeywell during the period that Honeywell was considered a related party are as follow:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Payments under agreements with Honeywell	$	—	$	2	$	2	$	6

Our payments under the agreements with Honeywell are included in Cost of goods sold and Selling, general and administrative expenses in our Consolidated Interim Statements of Operations. Related to the agreements with Honeywell, our Consolidated Balance Sheet at December 31, 2022 includes liabilities of $10 million. Liability balances are primarily related to lease contracts of $7 million as of December 31, 2022.

As discussed in Note 15, Series A Preferred Stock, in order to effect the Transaction, on April 12, 2023, the Company entered into separate definitive agreements with each of Centerbridge Partners, L.P. (“Centerbridge”) and funds managed by Oaktree Capital Management, L.P. (“Oaktree”), each of which is a holder of our Common Stock and appoints a director to our Board of Directors. Additionally, Mr. Kevin Mahony, who serves as a Managing Director of Centerbridge, and Mr. Steven Tesoriere, who serves as a Managing Director of Oaktree, have been appointed to our Board of Directors as designees of Centerbridge and Oaktree, respectively. As described more fully in Note 15, Series A Preferred Stock, in connection with the Transaction, we paid to Centerbridge and Oaktree an aggregate of approximately $570 million for the repurchase of shares of Series A Preferred Stock, plus an aggregate of approximately $10 million and 7,276,036 shares of Common Stock representing the Additional Amounts and Accumulated Dividends in respect of the repurchased shares of Series A Preferred Stock. Additionally, in connection with the conversion of the Series A Preferred Stock, we issued to Centerbridge and Oaktree an aggregate of 65,334,277 shares of Common Stock, plus Additional Amounts and Accumulated Dividends of approximately $9 million and 6,819,540 shares of Common Stock.

In connection with the conversion of our Series A Preferred Stock, we issued to Honeywell, as a holder of our Series A Preferred Stock, 4,196,330 shares of Common Stock upon the conversion of an equivalent number of shares of Series A Preferred Stock, plus Additional Amounts and Accumulated Dividends of approximately $1 million and 438,009 shares of Common Stock.

Additionally, Mr. John Petry, a director on our Board, serves as Managing Member of Sessa Capital (Master), L.P., which indirectly held shares of our Series A Preferred Stock prior to the conversion. In connection with the conversion of our Series A Preferred Stock, we issued to Sessa Capital and its affiliates, as holder of our Series A Preferred Stock, 16,592,384 shares of Common Stock upon the conversion of an equivalent number of shares of Series A Preferred Stock, plus Additional Amounts and Accumulated Dividends of approximately $2 million and 1,731,900 shares of Common Stock.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 20. Commitments and Contingencies

Securities Litigation

On September 25, 2020, a putative securities class action complaint was filed against Garrett Motion Inc. and certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. The case bears the caption: Steven Husson, Individually and On Behalf of All Others Similarly Situated, v. Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-07992-JPC (SDNY) (the “Husson Action”). The Husson Action asserted claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 as amended (the "Exchange Act"), for securities fraud and control person liability. On September 28, 2020, the

plaintiff sought to voluntarily dismiss his claim against Garrett Motion Inc. in light of the Company’s bankruptcy; this request was granted.

On October 5, 2020, another putative securities class action complaint was filed against certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. This case bears the caption: The Gabelli Asset Fund, The Gabelli Dividend & Income Trust, The Gabelli Value 25 Fund Inc., The Gabelli Equity Trust Inc., SM Investors LP and SM Investors II LP, on behalf of themselves and all others similarly situated, v. Su Ping Lu, Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Craig Balis, Thierry Mabru, Russell James, Carlos M. Cardoso, Maura J. Clark, Courtney M. Enghauser, Susan L. Main, Carsten Reinhardt, and Scott A. Tozier, Case No. 1:20-cv-08296-JPC (SDNY) (the “Gabelli Action”). The Gabelli Action also asserted claims under Sections 10(b) and 20(a) of the Exchange Act.

On November 5, 2020, another putative securities class action complaint was filed against certain current and former Garrett officers and directors in the United States District Court for the Southern District of New York. This case bears the caption: Joseph Froehlich, Individually and On Behalf of All Others Similarly Situated, v. Olivier Rabiller, Allesandro Gili, Peter Bracke, Sean Deason, and Su Ping Lu, Case No. 1:20-cv-09279-JPC (SDNY) (the “Froehlich Action”). The Froehlich Action also asserted claims under Sections 10(b) and 20(a) of the Exchange Act.

The actions were assigned to Judge John P. Cronan. On November 24, 2020, competing motions were filed seeking the appointment of lead plaintiff and lead counsel and the consolidation of the Husson, Gabelli, and Froehlich Actions.

On December 8, 2020, counsel for the plaintiffs in the Gabelli Action — the Entwistle & Cappucci law firm — filed an unopposed stipulation and proposed order that would (1) appoint the plaintiffs in the Gabelli Action — the “Gabelli Entities” — the lead plaintiffs; (2) would appoint Entwistle & Cappucci as lead counsel for the plaintiff class; and (3) consolidate the Gabelli Action, the Husson Action, and the Froehlich Action (the “Consolidated D&O Action”). On January 21, 2021, the Court granted the motion to consolidate the actions and granted the Gabelli Entities’ motions for appointment as lead plaintiff and for selection of lead counsel. On February 25, 2021, plaintiffs filed a Consolidated Amended Complaint.

The Company’s insurer, AIG, has accepted the defense, subject to the customary reservation of rights.

The Company agreed with the Gabelli Entities and their lead counsel to permit a class claim to be recognized in the bankruptcy court and to have securities claims against the Company to be litigated in the district court alongside the Consolidated D&O Action. The Gabelli Entities have agreed that any recoveries against Garrett Motion Inc. on account of securities claims litigated through the class claim are limited to available insurance policy proceeds. On July 2, 2021, the bankruptcy court entered an order approving the joint request from the Company and the Gabelli Entities to handle the securities claims against Garrett Motion Inc. in this manner.

The Gabelli Entities were authorized and, on July 22, 2021, filed a second amended complaint to add claims against Garrett Motion Inc. On August 11, 2021, Garrett Motion Inc., Olivier Rabiller, Alessandro Gili, Peter Bracke, Sean Deason, Russell James, Carlos Cardoso, Maura Clark, Courtney Enghauser, Susan Main, Carsten Reinhardt, and Scott Tozier filed a motion to dismiss with respect to claims asserted against them. On the same day, Su Ping Lu, who is represented separately, filed a motion to dismiss with respect to the claims asserted against her. Lead plaintiffs’ opposition to the motions to dismiss was filed on October 26, 2021, and the defendant's reply briefs were filed on or before December 8, 2021. On March 31, 2022, the judge dismissed the complaints entirely - Su Ping Lu's motion to dismiss was granted with prejudice while the court granted the plaintiffs 30 days to file a third amended complaint against the Company and the other defendants.

On May 2, 2022, the plaintiffs filed a Third Amended Complaint (“TAC”) against all of the foregoing Defendants apart from Alessandro Gili and Su Ping Lu. On June 24, 2022, defendants moved to dismiss the TAC in its entirety, with prejudice. Plaintiffs filed their opposition on August 16, 2022, and defendants filed their reply brief on September 23, 2022. On September 22, 2022, the action was reassigned from Judge John P. Cronan to Judge Jennifer L. Rochon, who was recently appointed. On March 31, 2023, the action was dismissed with prejudice. The plaintiffs filed an appeal and the defendants' opposition is due on October 31, 2023.

Brazilian Tax Matter

In September 2020, the Brazilian tax authorities issued an infraction notice against Garrett Motion Industria Automotiva Brasil Ltda, challenging the use of certain tax credits (“Befiex Credits”) between January 2017 and February 2020. The infraction notice results in a loss contingency that may or may not ultimately be incurred by the Company. The

estimated total amount of the contingency as of September 30, 2023 was $37 million including penalties and interest. The Company believes, based on management’s assessment and the advice of external legal counsel, that it has meritorious arguments in connection with the infraction notice and any liability for the infraction notice is currently not probable. Accordingly, no accrual is required at this time.

Warranties and Guarantees

In the normal course of business, we issue product warranties and product performance guarantees. We accrue for the estimated cost of product warranties and performance guarantees based on contract terms and historical experience at the time of sale to the customer. Adjustments to initial obligations for warranties and guarantees are made as changes to the obligations become reasonably estimable. Product warranties and product performance guarantees are included in Accrued Liabilities and Other Liabilities. The following table summarizes information concerning our recorded obligations for product warranties and product performance guarantees.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Warranty and product performance guarantees at beginning of period	$	27	$	30	$	28	$	32
Accruals for warranties/guarantees issued during the year	2		3		8		10
Settlement of warranty/guarantee claims	(2)		(2)		(9)		(10)
Foreign currency translation	(1)		(2)		(1)		(3)
Warranty and product performance guarantees at end of period	$	26	$	29	$	26	$	29

Other Commitments and Contingencies

We are subject to other lawsuits, investigations and disputes arising out of the conduct of our business, including matters relating to commercial transactions, government contracts, product liability, prior acquisitions and divestitures, employee benefit plans, intellectual property and environmental, health and safety matters. We recognize a liability for any contingency that is probable of occurring and reasonably estimable. We continually assess the likelihood of adverse judgments of outcomes in these matters, as well as potential ranges of possible losses (taking into consideration any insurance recoveries), based on a careful analysis of each matter with the assistance of outside legal counsel and, if applicable, other experts.

XML

Pension Benefits

9 Months Ended

Sep. 30, 2023

Retirement Benefits [Abstract]

Pension Benefits

Note 21. Pension Benefits

We sponsor several funded U.S. and non-U.S. defined benefit pension plans. Significant plans outside the U.S. are in Switzerland and Ireland. Other pension plans outside the U.S. are not material to the Company, either individually or in the aggregate.

Our general funding policy for qualified defined benefit pension plans is to contribute amounts at least sufficient to satisfy regulatory funding standards. We are not required to make any contributions to our U.S. pension plan in 2023. We expect to make contributions of cash and/or marketable securities of approximately $7 million to our non-U.S. pension plans to satisfy regulatory funding standards in 2023, of which $6 million has been contributed as of September 30, 2023.

Net periodic benefit costs for our significant defined benefit plans include the following components:

	Three Months Ended September 30,								Nine Months Ended September 30,
	U.S. Plans				Non-U.S. Plan				U.S. Plans				Non-U.S. Plan
	2023		2022		2023		2022		2023		2022		2023		2022
	(Dollars in millions)
Service cost	$	—	$	—	$	1	$	2	$	—	$	1	$	4	$	5
Interest cost	2		1		1		—		6		4		4		1
Expected return on plan assets	(2)		(2)		(2)		(2)		(6)		(6)		(6)		(5)
Amortization of prior service (credit)	—		—		—		—		—		—		(1)		—
	$	—	$	(1)	$	—	$	—	$	—	$	(1)	$	1	$	1

For both our U.S. and non-U.S. defined benefit pension plans, we estimate the service and interest cost components of net periodic benefit (income) cost by utilizing a full yield curve approach in the estimation of these cost components by applying the specific spot rates along the yield curve used in the determination of the pension benefit obligation to their underlying projected cash flows. This approach provides a more precise measurement of service and interest costs by improving the correlation between projected cash flows and their corresponding spot rates.

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income	$ 57	$ 71	$ 81	$ 105	$ 85	$ 88	$ 209	$ 278

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited Consolidated Interim Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission applicable to interim financial statements. While these statements reflect all normal recurring adjustments that are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by United States generally accepted accounting principles (“GAAP”) for complete financial statements. The unaudited Consolidated Interim Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and accompanying notes for the year ended December 31, 2022 included in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on February 14, 2023 (our “2022 Form 10-K”). The results of operations for the three and nine months ended September 30, 2023 and cash flows for the nine months ended September 30, 2023 should not necessarily be taken as indicative of the entire year. All amounts presented are in millions, except per share amounts.

We report our quarterly financial information using a calendar convention: the first, second and third quarters are consistently reported as ending on March 31, June 30 and September 30. It has been our practice to establish actual quarterly closing dates using a predetermined fiscal calendar, which requires our businesses to close their books on a Saturday to minimize the potentially disruptive effects of quarterly closing on our business processes. For differences in actual closing dates that are material to year-over-year comparisons of quarterly or year-to-date results, such differences have been adjusted for the three months ended September 30, 2022. Our actual closing date for the three months ended September 30, 2022 was October 1, 2022. There was no difference in actual closing date for the three months ended September 30, 2023.

We evaluate segment reporting in accordance with ASC 280, Segment Reporting. We concluded that Garrett operates in a single operating segment and a single reportable segment based on the operating results available and evaluated regularly by the chief operating decision maker (“CODM”), which is our Chief Executive Officer, to make decisions about resource allocation and performance assessment. The CODM makes operational performance assessments and resource allocation decisions on a consolidated basis, inclusive of all of the Company’s products across channels and geographies.

The preparation of the financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates on assumptions that it believes to be reasonable under the circumstances. Actual results could differ from the original estimates, requiring adjustments to these balances in future periods.

Recently Adopted and Issued Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In September 2022, the FASB issued ASU 2022-04, Disclosure of Supplier Finance Program Obligations (Topic 405-50): Disclosure of Supplier Finance Purchase Obligations. The amendment in this update requires companies to disclose key terms of supplier financing programs used in connection with the purchase of goods and services, along with information about their obligations under these programs including a rollforward of those obligations. The Company adopted the new guidance as of January 1, 2023. See Note 10, Supplier Financing for disclosure related to the Company's supplier financing program obligations.

XML

Background and Basis of Presentation (Tables)

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed financial statements

The Company recorded the following amounts in the Consolidated Interim Financial Statements related to the repurchase and conversion of its Series A Preferred Stock:

	Movements for the Nine Months Ended
	September 30, 2023
Consolidated Interim Balance Sheet:	(Dollars in millions)
Cash and cash equivalents	$	(605)
Preferred stock, Common stock and Additional Paid-in capital	(157)
Retained earnings	(441)
	Nine Months Ended September 30, 2023
Consolidated Interim Statement of Operations:	(Dollars in millions)
Non-operating expenses	$	13

The following table summarizes the effects of the Transaction on the Consolidated Interim Balance Sheet as of September 30, 2023 and the Consolidated Interim Statement of Operations and Consolidated Interim Statement of Cash Flows for the nine months ended September 30, 2023:

	Series A Repurchase		2023 Conversion		Settlement of Accumulated Dividends		Excise tax on share repurchase		Total
	(Dollars in millions)
Consolidated Interim Balance Sheet - increase/(decrease):
Cash and cash equivalents	$	(580)	$	(25)	$	—	$	—	$	(605)
Accrued liabilities	—		—		—		6		6
Preferred Stock	—		—		—		—		—
Common Stock	—		—		—		—		—
Additional Paid-in capital	(366)		—		209		—		(157)
Retained earnings	(201)		(25)		(209)		(6)		(441)
Consolidated Interim Statement of Operations:
Non-operating expenses	13		—		—		—		13
Consolidated Interim Statement of Cash Flows
Repurchases of Series A Preferred Stock	(580)		—		—		—		(580)
Payments for Additional Amounts for conversion of Series A Preferred Stock	—		(25)		—		—		(25)

XML

Revenue Recognition and Contracts with Customers (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Summary of Net Sales by Region and Channel

Net sales by region (determined based on country of shipment) and channel are as follows:

	Three Months Ended September 30, 2023								Three Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	147	$	54	$	2	$	203	$	134	$	54	$	1	$	189
Europe	382		45		9		436		381		41		6		428
Asia	287		13		5		305		288		14		6		308
Other	9		6		1		16		14		6		—		20
	$	825	$	118	$	17	$	960	$	817	$	115	$	13	$	945
	Nine Months Ended September 30, 2023								Nine Months Ended September 30, 2022
	OEM		Aftermarket		Other		Total		OEM		Aftermarket		Other		Total
	(Dollars in millions)
United States	$	412	$	150	$	4	$	566	$	354	$	159	$	2	$	515
Europe	1,265		136		26		1,427		1,181		117		21		1,319
Asia	846		38		12		896		765		34		18		817
Other	33		18		1		52		36		18		—		54
	$	2,556	$	342	$	43	$	2,941	$	2,336	$	328	$	41	$	2,705

Summary of Contract Assets and Liabilities

The following table summarizes our contract assets and liabilities balances:

	2023		2022
	(Dollars in millions)
Contract assets—January 1	$	46	$	63
Contract assets—September 30	44		51
Change in contract assets—(Decrease)/Increase	$	(2)	$	(12)
Contract liabilities—January 1	$	(8)	$	(5)
Contract liabilities—September 30	(12)		(9)
Change in contract liabilities—(Increase)/Decrease	$	(4)	$	(4)

XML

Research, Development & Engineering (Tables)

9 Months Ended

Sep. 30, 2023

Research and Development [Abstract]

Summary of Research, Development & Engineering Activities

Such costs are included in Cost of goods sold as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Research and development costs	$	42	$	38	$	128	$	112
Engineering-related expenses, net of customer (reimbursements) (1)	(3)		4		(8)		13
	$	39	$	42	$	120	$	125

(1)    Engineering-related expenses include customer reimbursements of $10 million and $6 million for the three months ended September 30, 2023 and 2022, respectively, and $34 million and $15 million for the nine months ended September 30, 2023 and 2022, respectively.

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2023

Income Tax Disclosure [Abstract]

Tax Expense (Benefit) and Effective Tax Rate

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
	(Dollars in millions)
Tax expense	$	13		$	26		$	70		$	83
Effective tax rate	18.6		%	19.8		%	25.1		%	23.0		%

XML

Accounts, Notes and Other Receivables-Net (Tables)

9 Months Ended

Sep. 30, 2023

Receivables [Abstract]

Schedule of Accounts, Notes and Other Receivables Net

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Trade receivables	$	667	$	619
Notes receivable	111		105
Other receivables	89		88
	867		812
Less—Allowance for expected credit losses	(7)		(9)
	$	860	$	803

XML

Factoring and Notes Receivable (Tables)

9 Months Ended

Sep. 30, 2023

Receivables [Abstract]

Disclosure of Detailed Information about Trade Receivables and Guaranteed Bank Notes

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Eligible receivables sold without recourse	$	184	$	112	$	584	$	481
Guaranteed bank notes sold without recourse	41		35		41		102

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Receivables sold but not yet collected by the bank from the customer	$	7	$	5
Guaranteed bank notes sold but not yet collected by the bank from the customer	—		—

XML

Inventories-Net (Tables)

9 Months Ended

Sep. 30, 2023

Inventory Disclosure [Abstract]

Summary of Inventories

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Raw materials	$	197	$	203
Work in process	24		18
Finished products	110		80
	331		301
Less—Reserves	(37)		(31)
	$	294	$	270

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Assets

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Advanced discounts to customers, non-current	$	41	$	51
Operating right-of-use assets (Note 13)	40		44
Income tax receivable	22		22
Pension and other employee related	4		4
Designated cross-currency swaps	71		74
Designated and undesignated derivatives	66		76
Other	11		10
	$	255	$	281

XML

Supplier Financing (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Supplier Finance Program

The supplier financing obligations and guaranteed bank notes outstanding are recorded within Accounts payable in our Consolidated Interim Balance Sheet.

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Supplier financing obligations outstanding with financial institutions	$	67	$	33
Guaranteed bank notes outstanding	172		171

XML

Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Accrued Liabilities, Current [Abstract]

Summary of Accrued Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Customer pricing reserve	$	64	$	50
Compensation, benefit and other employee related	74		69
Repositioning	12		9
Product warranties and performance guarantees - short-term (Note 20)	17		18
Income and other taxes	55		39
Advanced discounts from suppliers, current	4		8
Customer advances and deferred income (1)	18		29
Accrued interest	25		13
Short-term lease liability (Note 13)	9		9
Accrued freight	13		9
Dividends payable	—		42
Designated and undesignated derivatives	8		8
Other (primarily operating expenses) (2)	13		17
	312		320

(1)Customer advances and deferred income include $12 million and $8 million of contract liabilities as of September 30, 2023 and December 31, 2022, respectively. See Note 3, Revenue Recognition and Contracts with Customers.

(2)Includes $3 million and $3 million of environmental liabilities as of September 30, 2023 and December 31, 2022, respectively.

Summary of Expenses Related to the Repositioning Accruals

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2022	$	9	$	—	$	9
Charges	13		2		15
Usage—cash	(10)		—		(10)
Non-cash asset write-offs	—		(2)		(2)
Balance at September 30, 2023	$	12	$	—	$	12

	Severance Costs		Other Costs		Total
	(Dollars in millions)
Balance at December 31, 2021	$	10	$	—	$	10
Charges	4		—		4
Usage—cash	(5)		—		(5)
Balance at September 30, 2022	$	9	$	—	$	9

XML

Other Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Other Liabilities Disclosure [Abstract]

Schedule of Other Liabilities

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Income taxes	$	104	$	99
Pension and other employee related	17		21
Long-term lease liability (Note 13)	33		36
Advanced discounts from suppliers	3		6
Product warranties and performance guarantees – long-term (Note 20)	9		10
Environmental remediation – long term	12		14
Long-term accounts payable	7		8
Other	11		11
	196		205

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2023

Leases [Abstract]

Summary of Components of Lease Expense

The components of lease expense are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Operating lease cost	$	4	$	4	$	12	$	12

Summary of Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to operating leases is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	3	$	3	$	10	$	9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	—		2		2		4

Summary of Supplemental Balance Sheet Information Related to Operating Leases

Supplemental balance sheet information related to operating leases is as follows:

	September 30, 2023		December 31, 2022
	(Dollars in millions)
Other assets	$	40	$	44
Accrued liabilities	9		9
Other liabilities	33		36

	September 30, 2023		December 31, 2022
Weighted-average remaining lease term (in years)	8.14		8.41
Weighted-average discount rate	5.69	%	5.61	%

Schedule of Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities as of September 30, 2023 were as follows:

	(Dollars in millions)
2023	$	3
2024	10
2025	8
2026	6
2027	5
Thereafter	20
Total lease payments	52
Less imputed interest	(11)
	$	41

XML

Long-term Debt and Credit Agreements (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of principal outstanding and carrying amount of long term debt

The principal outstanding and carrying amounts of our long-term debt as of September 30, 2023 and December 31, 2022 are as follows:

	Due	Interest Rate	September 30, 2023		December 31, 2022
2021 Dollar Term Facility	4/30/2028	SOFR plus 351 bps	$	700	$	706
2023 Dollar Term Facility	4/30/2028	SOFR plus 450 bps	500		—
Euro Term Facility	4/30/2028	EURIBOR plus 350 bps	477		480
Total principal outstanding			1,677		1,186
Less: unamortized deferred financing costs			(48)		(31)
Less: current portion of long-term debt			(7)		(7)
Total long-term debt			$	1,622	$	1,148

Schedule of maturities of long-term debt

Minimum scheduled principal repayments of the Credit Facilities as of September 30, 2023 are as follow:

	September 30, 2023
	(Dollars in millions)
2023	$	2
2024	7
2025	7
2026	17
2027	77
Thereafter	1,567
Total debt payments	$	1,677

XML

Series A Preferred Stock (Tables)

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

Condensed financial statements

The Company recorded the following amounts in the Consolidated Interim Financial Statements related to the repurchase and conversion of its Series A Preferred Stock:

	Movements for the Nine Months Ended
	September 30, 2023
Consolidated Interim Balance Sheet:	(Dollars in millions)
Cash and cash equivalents	$	(605)
Preferred stock, Common stock and Additional Paid-in capital	(157)
Retained earnings	(441)
	Nine Months Ended September 30, 2023
Consolidated Interim Statement of Operations:	(Dollars in millions)
Non-operating expenses	$	13

The following table summarizes the effects of the Transaction on the Consolidated Interim Balance Sheet as of September 30, 2023 and the Consolidated Interim Statement of Operations and Consolidated Interim Statement of Cash Flows for the nine months ended September 30, 2023:

	Series A Repurchase		2023 Conversion		Settlement of Accumulated Dividends		Excise tax on share repurchase		Total
	(Dollars in millions)
Consolidated Interim Balance Sheet - increase/(decrease):
Cash and cash equivalents	$	(580)	$	(25)	$	—	$	—	$	(605)
Accrued liabilities	—		—		—		6		6
Preferred Stock	—		—		—		—		—
Common Stock	—		—		—		—		—
Additional Paid-in capital	(366)		—		209		—		(157)
Retained earnings	(201)		(25)		(209)		(6)		(441)
Consolidated Interim Statement of Operations:
Non-operating expenses	13		—		—		—		13
Consolidated Interim Statement of Cash Flows
Repurchases of Series A Preferred Stock	(580)		—		—		—		(580)
Payments for Additional Amounts for conversion of Series A Preferred Stock	—		(25)		—		—		(25)

XML

Financial Instruments and Fair Value Measures (Tables)

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis

The following table sets forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2023 and December 31, 2022:

					Fair Value
	Notional Amounts				Assets					Liabilities
	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022			September 30, 2023		December 31, 2022
Designated instruments:
Designated forward currency exchange contracts	$	449	$	565	$	15	$	22	(a)	$	6	$	6	(c)
Designated cross-currency swaps	1,015		715		71		74		(b)	—		—
Designated interest-rate swaps	200		—		1		—		(b)	—		—
Total designated instruments	1,664		1,280		87		96			6		6
Undesignated instruments:
Undesignated interest rate swaps	879		1,024		65		76		(b)	—		—
Undesignated forward currency exchange contracts	341		317		3		4		(a)	2		2		(c)
Total undesignated instruments	1,220		1,341		68		80			2		2
Total designated and undesignated instruments	$	2,884	$	2,621	$	155	$	176		$	8	$	8

(a) Recorded within Other current assets

(b) Recorded within Other assets

(c) Recorded within Accrued liabilities

Summary of Financial Assets and Liabilities Not Carried at Fair Value

The following table sets forth the Company’s financial assets and liabilities that were not carried at fair value:

	September 30, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
	(Dollars in millions)
Term Loan Facilities	$	1,629	$	1,671	$	1,156	$	1,151

XML

Accumulated Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Summary of Changes in Accumulated Other Comprehensive Income (Loss) by Component

The changes in Accumulated Other Comprehensive Income by component are set forth below:

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2022	$	(44)	$	13	$	85	$	(18)	$	36
Other comprehensive income before reclassifications	8		17		18		—		43
Amounts reclassified from accumulated other comprehensive income	—		(20)		—		—		(20)
Net current period other comprehensive income	8		(3)		18		—		23
Balance at September 30, 2023	$	(36)	$	10	$	103	$	(18)	$	59

	Foreign Exchange Translation Adjustment		Changes in Fair Value of Effective Cash Flow Hedges		Changes in Fair Value of Net Investment Hedges		Pension Adjustments		Total Accumulated Other Comprehensive Income
	(Dollars in millions)
Balance at December 31, 2021	$	(43)	$	7	$	41	$	(9)	$	(4)
Other comprehensive income before reclassifications	13		43		87		—		143
Amounts reclassified from accumulated other comprehensive income	—		(17)		—		—		(17)
Net current period other comprehensive income	13		26		87		—		126
Balance at September 30, 2022	$	(30)	$	33	$	128	$	(9)	$	122

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The details of the EPS calculations for the three and nine months ended September 30, 2023 and 2022 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions except per share)
Basic earnings per share:
Net income	$	57	$	105	$	209	$	278
Less: preferred stock dividend	—		(40)		(80)		(117)
Less: preferred stock deemed dividends	—		—		(232)		—
Net (loss) income available for distribution	57		65		(103)		161
Less: earnings allocated to participating securities	—		(51)		—		(127)
Net (loss) income available to common shareholders	$	57	$	14	$	(103)	$	34
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
EPS – Basic	$	0.23	$	0.21	$	(0.73)	$	0.52
Diluted earnings per share:
Method used:			Two-class		Two-class		Two-class
Weighted average common shares outstanding - Basic	250,888,716		64,820,887		141,745,701		64,834,298
Dilutive effect of unvested RSUs and other contingently issuable shares	1,493,003		429,400		—		283,723
Weighted average common shares outstanding – Diluted	252,381,719		65,250,287		141,745,701		65,118,021
EPS – Diluted	$	0.23	$	0.21	$	(0.73)	$	0.52

XML

Related Party Transactions (Tables)

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

Our payments under the agreements with Honeywell during the period that Honeywell was considered a related party are as follow:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Payments under agreements with Honeywell	$	—	$	2	$	2	$	6

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Summary Information Concerning our Recorded Obligations for Product Warranties and Product Performance Guarantees

The following table summarizes information concerning our recorded obligations for product warranties and product performance guarantees.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(Dollars in millions)
Warranty and product performance guarantees at beginning of period	$	27	$	30	$	28	$	32
Accruals for warranties/guarantees issued during the year	2		3		8		10
Settlement of warranty/guarantee claims	(2)		(2)		(9)		(10)
Foreign currency translation	(1)		(2)		(1)		(3)
Warranty and product performance guarantees at end of period	$	26	$	29	$	26	$	29

XML

Pension Benefits (Tables)

9 Months Ended

Sep. 30, 2023

Retirement Benefits [Abstract]

Summary of Net Periodic Benefit Cost

Net periodic benefit costs for our significant defined benefit plans include the following components:

	Three Months Ended September 30,								Nine Months Ended September 30,
	U.S. Plans				Non-U.S. Plan				U.S. Plans				Non-U.S. Plan
	2023		2022		2023		2022		2023		2022		2023		2022
	(Dollars in millions)
Service cost	$	—	$	—	$	1	$	2	$	—	$	1	$	4	$	5
Interest cost	2		1		1		—		6		4		4		1
Expected return on plan assets	(2)		(2)		(2)		(2)		(6)		(6)		(6)		(5)
Amortization of prior service (credit)	—		—		—		—		—		—		(1)		—
	$	—	$	(1)	$	—	$	—	$	—	$	(1)	$	1	$	1

XML

Background and Basis of Presentation - Additional Information (Details) $ in Millions			9 Months Ended
	Jun. 06, 2023 shares	Apr. 12, 2023 USD ($) shares	Sep. 30, 2023 USD ($) Segment	Apr. 27, 2023 USD ($)
Debt and Equity Securities, FV-NI [Line Items]
Number of operating segments | Segment			1
Number of reportable segments | Segment			1
Stock repurchased during period, transaction-related costs | $			$ 9
2023 Dollar Term Facility | Credit Agreement | Secured debt
Debt and Equity Securities, FV-NI [Line Items]
Line of credit, maximum borrowing capacity | $				$ 700
Series A Cumulative Convertible Preferred Stock
Debt and Equity Securities, FV-NI [Line Items]
Stock repurchased during period, (in shares) | shares		69,707,719
Conversion of stock, shares converted (in shares) | shares	175,337,712	175,337,712
Payments for repurchase of convertible preferred stock | $		$ 605
Common Stock
Debt and Equity Securities, FV-NI [Line Items]
Issuance of common stock for preference dividends (in shares) | shares	25,577,517	25,577,517

XML

Background and Basis of Presentation - Schedule of Capital Structure Transformation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Condensed Financial Statements, Captions [Line Items]
Non-operating expenses	$ 4	$ 29	$ 1	$ 73
Total
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents			(605)
Preferred stock, Common stock and Additional Paid-in capital			(157)
Retained deficit			(441)
Non-operating expenses			$ 13

XML

Revenue Recognition and Contracts with Customers - Summary of Net Sales by Region and Channel (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation Of Revenue [Line Items]
Net sales	$ 960	$ 945	$ 2,941	$ 2,705
United States
Disaggregation Of Revenue [Line Items]
Net sales	203	189	566	515
Europe
Disaggregation Of Revenue [Line Items]
Net sales	436	428	1,427	1,319
Asia
Disaggregation Of Revenue [Line Items]
Net sales	305	308	896	817
Other
Disaggregation Of Revenue [Line Items]
Net sales	16	20	52	54
OEM
Disaggregation Of Revenue [Line Items]
Net sales	825	817	2,556	2,336
OEM | United States
Disaggregation Of Revenue [Line Items]
Net sales	147	134	412	354
OEM | Europe
Disaggregation Of Revenue [Line Items]
Net sales	382	381	1,265	1,181
OEM | Asia
Disaggregation Of Revenue [Line Items]
Net sales	287	288	846	765
OEM | Other
Disaggregation Of Revenue [Line Items]
Net sales	9	14	33	36
Aftermarket
Disaggregation Of Revenue [Line Items]
Net sales	118	115	342	328
Aftermarket | United States
Disaggregation Of Revenue [Line Items]
Net sales	54	54	150	159
Aftermarket | Europe
Disaggregation Of Revenue [Line Items]
Net sales	45	41	136	117
Aftermarket | Asia
Disaggregation Of Revenue [Line Items]
Net sales	13	14	38	34
Aftermarket | Other
Disaggregation Of Revenue [Line Items]
Net sales	6	6	18	18
Other
Disaggregation Of Revenue [Line Items]
Net sales	17	13	43	41
Other | United States
Disaggregation Of Revenue [Line Items]
Net sales	2	1	4	2
Other | Europe
Disaggregation Of Revenue [Line Items]
Net sales	9	6	26	21
Other | Asia
Disaggregation Of Revenue [Line Items]
Net sales	5	6	12	18
Other | Other
Disaggregation Of Revenue [Line Items]
Net sales	$ 1	$ 0	$ 1	$ 0

XML

Revenue Recognition and Contracts with Customers - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Change in Contract with Customer, Asset [Abstract]
Contract assets—January 1	$ 46	$ 63
Contract assets—September 30	44	51
Change in contract assets—(Decrease)/Increase	(2)	(12)
Change in Contract with Customer, Liability [Abstract]
Contract liabilities—January 1	(8)	(5)
Contract liabilities—September 30	(12)	(9)
Change in contract liabilities—(Increase)/Decrease	$ (4)	$ (4)

XML

Research, Development & Engineering (Details) - Cost of goods sold - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research, development & engineering expense, total	$ 39	$ 42	$ 120	$ 125
Research and development costs
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research, development & engineering expense, total	42	38	128	112
Engineering-related expenses, net of customer (reimbursements)
Research And Development Arrangement Contract To Perform For Others [Line Items]
Research, development & engineering expense, total	(3)	4	(8)	13
Customer reimbursement	$ 10	$ 6	$ 34	$ 15

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Tax expense	$ 13	$ 26	$ 70	$ 83
Effective tax rate	18.60%	19.80%	25.10%	23.00%

XML

Accounts, Notes and Other Receivables-Net - Schedule of Accounts, Notes and Other Receivables-Net (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Trade receivables	$ 667	$ 619
Notes receivable	111	105
Other receivables	89	88
Accounts, notes and other receivables, gross	867	812
Less—Allowance for expected credit losses	(7)	(9)
Accounts, notes and other receivables, net	$ 860	$ 803

XML

Accounts, Notes and Other Receivables-Net - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Unbilled balances	$ 44	$ 46

XML

Factoring and Notes Receivable - Disclosure of Detailed Information about Trade Receivables (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Receivables [Abstract]
Eligible receivables sold without recourse	$ 184	$ 112	$ 584	$ 481
Guaranteed bank notes sold without recourse	$ 41	$ 35	$ 41	$ 102

XML

Factoring and Notes Receivable - Disclosure of Detailed Information about Guaranteed Bank Notes (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Receivables sold but not yet collected by the bank from the customer	$ 7	$ 5
Guaranteed bank notes sold but not yet collected by the bank from the customer	$ 0	$ 0

XML

Factoring and Notes Receivable - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Receivables [Abstract]
Factoring and notes receivables discount fees	$ 1	$ 3

XML

Inventories-Net (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 197	$ 203
Work in process	24	18
Finished products	110	80
Inventories, gross	331	301
Less—Reserves	(37)	(31)
Inventories, net	$ 294	$ 270

XML

Other Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Advanced discounts to customers, non-current	$ 41	$ 51
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Total other assets	Total other assets
Operating right-of-use assets (Note 13)	$ 40	$ 44
Income tax receivable	22	22
Pension and other employee related	4	4
Designated cross-currency swaps	71	74
Designated and undesignated derivatives	66	76
Other	11	10
Total other assets	$ 255	$ 281

XML

Supplier Financing - Narrative (Details)	9 Months Ended
	Sep. 30, 2023 institution
Supply Commitment [Line Items]
Number of third party financial institutions	2
Guaranteed bank notes outstanding
Supply Commitment [Line Items]
Supplier finance program, payment timing, period	6 months

XML

Supplier Financing (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Supplier financing obligations outstanding with financial institutions
Supply Commitment [Line Items]
Supplier finance program, obligation	$ 67	$ 33
Guaranteed bank notes outstanding
Supply Commitment [Line Items]
Supplier finance program, obligation	$ 172	$ 171

XML

Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Accrued Liabilities, Current [Abstract]
Customer pricing reserve	$ 64	$ 50
Compensation, benefit and other employee related	74	69
Repositioning	12	9
Product warranties and performance guarantees - short-term (Note 20)	17	18
Income and other taxes	55	39
Advanced discounts from suppliers, current	4	8
Customer advances and deferred income	18	29
Accrued interest	$ 25	$ 13
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities (Note 11)	Accrued liabilities (Note 11)
Short-term lease liability (Note 13)	$ 9	$ 9
Accrued freight	13	9
Dividends payable	0	42
Designated and undesignated derivatives	8	8
Other (primarily operating expenses)	13	17
Accrued liabilities (Note 11)	312	320
Contract liabilities	12	8
Accrued environmental liability	$ 3	$ 3

XML

Accrued Liabilities - Summary of Expenses Related to the Repositioning Accruals (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 9	$ 10
Charges	15	4
Usage—cash	(10)	(5)
Non-cash asset write-offs	(2)
Balance at end of period	12	9
Severance Costs
Restructuring Reserve [Roll Forward]
Balance at beginning of period	9	10
Charges	13	4
Usage—cash	(10)	(5)
Non-cash asset write-offs	0
Balance at end of period	12	9
Other Costs
Restructuring Reserve [Roll Forward]
Balance at beginning of period	0	0
Charges	2	0
Usage—cash	0	0
Non-cash asset write-offs	(2)
Balance at end of period	$ 0	$ 0

XML

Other Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Income taxes	$ 104	$ 99
Pension and other employee related	$ 17	$ 21
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Total other liabilities	Total other liabilities
Long-term lease liability (Note 13)	$ 33	$ 36
Advanced discounts from suppliers	3	6
Product warranties and performance guarantees – long-term (Note 20)	9	10
Environmental remediation – long term	12	14
Long-term accounts payable	7	8
Other	11	11
Total other liabilities	$ 196	$ 205

XML

Leases - Additional Information (Details) - Maximum	9 Months Ended
	Sep. 30, 2023
Lessee Lease Description [Line Items]
Operating lease, remaining lease terms	15 years
Operating lease, options to extend, years	2 years

XML

Leases - Summary of Components of Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 4	$ 4	$ 12	$ 12

XML

Leases - Summary of Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$ 3	$ 3	$ 10	$ 9
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 0	$ 2	$ 2	$ 4

XML

Leases - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets (Note 9)	Other assets (Note 9)
Other assets	$ 40	$ 44
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities (Note 11)	Accrued liabilities (Note 11)
Accrued liabilities	$ 9	$ 9
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other liabilities (Note 12)	Other liabilities (Note 12)
Other liabilities	$ 33	$ 36
Weighted-average remaining lease term (in years)	8 years 1 month 20 days	8 years 4 months 28 days
Weighted-average discount rate	5.69%	5.61%

XML

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Millions	Sep. 30, 2023 USD ($)
Leases [Abstract]
2023	$ 3
2024	10
2025	8
2026	6
2027	5
Thereafter	20
Total lease payments	52
Less imputed interest	(11)
Operating lease, liabilities	$ 41

XML

Long-term Debt and Credit Agreements - Schedule of Principal Outstanding And Carrying Amount of Long term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total debt payments	$ 1,677	$ 1,186
Less: unamortized deferred financing costs	(48)	(31)
Less: current portion of long-term debt	(7)	(7)
Total long-term debt	$ 1,622	1,148
2021 Dollar Term Facility
Debt Instrument [Line Items]
Long term debt, interest rate	3.51%
Total debt payments	$ 700	706
2023 Dollar Term Facility
Debt Instrument [Line Items]
Long term debt, interest rate	4.50%
Total debt payments	$ 500	0
Euro Term Facility
Debt Instrument [Line Items]
Long term debt, interest rate	3.50%
Total debt payments	$ 477	$ 480

XML

Long-term Debt and Credit Agreements - Schedule of maturities of long-term debt (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2023	$ 2
2024	7
2025	7
2026	17
2027	77
Thereafter	1,567
Total debt payments	$ 1,677	$ 1,186

XML

Long-term Debt and Credit Agreements - Additional Information (Details) € in Millions				9 Months Ended
	Jul. 31, 2023 USD ($)	Apr. 27, 2023 USD ($)	Apr. 30, 2021 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 14, 2022 USD ($)	Apr. 30, 2021 EUR (€)
Debt Instrument [Line Items]
Debt instrument, interest payment period if applicable period exceeds three months				3 months
Eurodollar
Debt Instrument [Line Items]
Debt instrument, interest rate at option				3.50%
Minimum | ABR
Debt Instrument [Line Items]
Debt instrument, interest rate at option				0.00%
Credit Agreement
Debt Instrument [Line Items]
Percentage of excess cash flow proceeds starting December 31, 2022				50.00%
Percentage of excess cash flow proceeds thereafter year 1				25.00%
Percentage of excess cash flow proceeds thereafter year 2				0.00%
Debt instrument face amount				$ 30,000,000
Aggregate commitment percentage				35.00%
Credit Agreement | Maximum
Debt Instrument [Line Items]
Consolidated total leverage ratio				4.7
U.S. Dollar Term Loan Facility | ABR
Debt Instrument [Line Items]
Debt instrument, interest rate at option				2.25%
U.S. Dollar Term Loan Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument, interest rate at option				3.51%
U.S. Dollar Term Loan Facility | Minimum | ABR
Debt Instrument [Line Items]
Debt instrument, interest rate at option				1.50%
U.S. Dollar Term Loan Facility | Minimum | Eurodollar
Debt Instrument [Line Items]
Debt instrument, interest rate at option				0.00%
U.S. Dollar Term Loan Facility | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument, interest rate at option				0.50%
2023 Dollar Term Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument, interest rate at option				4.50%
2023 Dollar Term Facility | Base Rate
Debt Instrument [Line Items]
Debt instrument, interest rate at option				3.50%
2023 Dollar Term Facility | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument, interest rate at option				0.50%
Term Loan Facility | Credit Agreement, USD tranche | Secured debt
Debt Instrument [Line Items]
Line of credit, term			7 years
Line of credit, maximum borrowing capacity			$ 715,000,000
Term Loan Facility | Credit Agreement, EUR tranche | Secured debt
Debt Instrument [Line Items]
Line of credit, term			7 years
Line of credit, maximum borrowing capacity | €							€ 450
Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Debt instrument, interest rate at option				1.00%
Unused commitment fee percentage				0.25%
Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Unused commitment fee percentage				0.50%
Revolving Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity					$ 125,000,000
Revolving Credit Facility | Credit Agreement
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity		$ 570,000,000
Line of credit facility, increase (decrease) in maximum borrowing capacity		$ 95,000,000
Line of credit facility, extension period		2 years
Line of credit				$ 0
Line of credit, available borrowing capacity				570,000,000
Revolving Credit Facility | Credit Agreement | Secured debt
Debt Instrument [Line Items]
Line of credit, term			5 years
Line of credit, maximum borrowing capacity			$ 300,000,000		$ 475,000,000
2023 Dollar Term Facility | Credit Agreement | Secured debt
Debt Instrument [Line Items]
Line of credit, term		5 years
Line of credit, maximum borrowing capacity		$ 700,000,000
Line of credit facility, first period		2 years
Limit period after closing date to prepay credit facility		12 months
Repayments of lines of credit	$ 200,000,000
2023 Dollar Term Facility | Credit Agreement | Secured debt | Interest income
Debt Instrument [Line Items]
Increase of amortization of financing costs	$ 9,000,000
2023 Dollar Term Facility | Credit Agreement | Secured debt | First Term
Debt Instrument [Line Items]
Line of credit facility, periodic payment, percentage of aggregate principal amount		7.50%
2023 Dollar Term Facility | Credit Agreement | Secured debt | Second Term
Debt Instrument [Line Items]
Line of credit facility, periodic payment, percentage of aggregate principal amount		10.00%
Undrawn Letters of credit | Credit Agreement
Debt Instrument [Line Items]
Line of credit				0
Letter of Credit
Debt Instrument [Line Items]
Line of credit				12,000,000
Line of credit, available borrowing capacity				$ 3,000,000
Line of credit, current borrowing capacity						$ 15,000,000

XML

Series A Preferred Stock - Narrative (Details) $ / shares in Units, $ in Millions			3 Months Ended				9 Months Ended
	Jun. 06, 2023 USD ($) d $ / shares shares	Apr. 12, 2023 USD ($) d $ / shares shares	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)
Class Of Stock [Line Items]
Equity interests issued and issuable, entity common shares issued per existing preferred share (in shares) | shares		0.104379
Payments of Additional Amounts for conversion of Series A Preferred Stock	$ 25						$ 25	$ 0
Stock repurchase program, fair value assumptions, dividend yield (in percentage)	0.00%
Stock repurchase program, fair value assumptions, expected volatility (in percentage)	40.00%
Stock repurchase program, fair value assumptions, risk-free interest rate (in percentage)	4.23%
Forward contract indexed to equity, settlement, share, fair value	$ 4
Loss on remeasurement of forward purchase contract	13						13	$ 0
Excise tax on share repurchases			$ 1	$ 6
Restrictions, changes to governance rights, maximum term		12 months
Restrictions, limits to the purchase equity securities, maximum term		18 months
Stock repurchased during period, transaction-related costs							$ 9
Common Stock Repurchase Program
Class Of Stock [Line Items]
Stock repurchase program, authorized amount		$ 250
Retained Deficit
Class Of Stock [Line Items]
Stock repurchases			161
Excise tax on share repurchases	$ 6		1	6
Series A Cumulative Convertible Preferred Stock
Class Of Stock [Line Items]
Stock repurchase program, authorized amount		$ 570
Stock repurchase program, price per share (in USD per share) | $ / shares		$ 8.10
Volume-weighted average share price calculation trading days | d	15	15
Stock repurchase program, Volume-Weighted Average share price (in USD per share) | $ / shares		$ 8.177
Payments for repurchase of convertible preferred stock		$ 605
Stock repurchased during period, (in shares) | shares		69,707,719
Conversion of stock, shares converted (in shares) | shares	175,337,712	175,337,712
Stock repurchase program, starting price per share (in USD per share) | $ / shares	$ 8.25
Stock repurchases			1	567	$ 1	$ 2
Series A Cumulative Convertible Preferred Stock | Retained Deficit
Class Of Stock [Line Items]
Stock repurchases	$ 201			201		$ 1
Series A Cumulative Convertible Preferred Stock | Related Party
Class Of Stock [Line Items]
Payments for repurchase of convertible preferred stock	$ 580
Stock repurchased during period, (in shares) | shares	69,707,719
Series A Cumulative Convertible Preferred Stock | Accumulate Dividend
Class Of Stock [Line Items]
Preferred stock, dividends per share, declared (in USD per share) | $ / shares		$ 0.853509
Dividends, preferred stock, stock	$ 209
Series A Cumulative Convertible Preferred Stock | Additional Amounts
Class Of Stock [Line Items]
Preferred stock, dividends per share, declared (in USD per share) | $ / shares		0.144375
Series A Cumulative Convertible Preferred Stock | Additional Amounts | Related Party
Class Of Stock [Line Items]
Aggregate accumulated dividend	$ 10
Series A Cumulative Convertible Preferred Stock | Minimum
Class Of Stock [Line Items]
Stock repurchase program, price per share (in USD per share) | $ / shares		7.875
Series A Cumulative Convertible Preferred Stock | Maximum
Class Of Stock [Line Items]
Stock repurchase program, price per share (in USD per share) | $ / shares		$ 8.50
Common Stock
Class Of Stock [Line Items]
Conversion of stock, shares issued (in shares) | shares	175,337,712
Issuance of common stock for preference dividends (in shares) | shares	25,577,517	25,577,517
Stock repurchases			$ 161	18
Common Stock | Retained Deficit
Class Of Stock [Line Items]
Stock repurchases				$ 18
Common Stock | Additional Amounts
Class Of Stock [Line Items]
Dividends, common stock	$ 25

XML

Series A Preferred Stock (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Jun. 06, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Condensed Financial Statements, Captions [Line Items]
Accrued liabilities				$ 26	$ (2)
Non-operating expenses		$ 4	$ 29	1	73
Share repurchases				(580)	(4)
Payments of Additional Amounts for conversion of Series A Preferred Stock	$ (25)			(25)	$ 0
Series A Repurchase
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents				(580)
Accrued liabilities				0
Preferred Stock				0
Common Stock				0
Additional paid–in capital				(366)
Retained deficit				(201)
Non-operating expenses				13
Share repurchases				(580)
Payments of Additional Amounts for conversion of Series A Preferred Stock				0
2023 Conversion
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents				(25)
Accrued liabilities				0
Preferred Stock				0
Common Stock				0
Additional paid–in capital				0
Retained deficit				(25)
Non-operating expenses				0
Share repurchases				0
Payments of Additional Amounts for conversion of Series A Preferred Stock				(25)
Settlement of Accumulated Dividends
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents				0
Accrued liabilities				0
Preferred Stock				0
Common Stock				0
Additional paid–in capital				209
Retained deficit				(209)
Non-operating expenses				0
Share repurchases				0
Payments of Additional Amounts for conversion of Series A Preferred Stock				0
Excise tax on share repurchase
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents				0
Accrued liabilities				6
Preferred Stock				0
Common Stock				0
Additional paid–in capital				0
Retained deficit				(6)
Non-operating expenses				0
Share repurchases				0
Payments of Additional Amounts for conversion of Series A Preferred Stock				0
Total
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents				(605)
Accrued liabilities				6
Preferred Stock				0
Common Stock				0
Additional paid–in capital				(157)
Retained deficit				(441)
Non-operating expenses				13
Share repurchases				(580)
Payments of Additional Amounts for conversion of Series A Preferred Stock				$ (25)

XML

Financial Instruments and Fair Value Measures - Additional Information (Details) € in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	May 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 EUR (€)	Dec. 31, 2022 USD ($)
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, aggregate gross notional amount		$ 2,884,000,000		$ 2,884,000,000			$ 2,621,000,000
Changes in fair value of net investment hedges, net of tax (Note 16)		20,000,000	$ 45,000,000	18,000,000	$ 87,000,000
Interest rate swap | Undesignated as hedging
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, aggregate gross notional amount | €						€ 830
Interest rate swap | Designated as hedging
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, aggregate gross notional amount | €						200
Fair value, assets		1,000,000		1,000,000
Cross-currency interest rate swaps
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, cash received on hedge	$ 9,000,000
Fair value of derivative assets, net		71,000,000		71,000,000
Changes in fair value of net investment hedges, net of tax (Note 16)		$ 20,000,000		18,000,000
Ineffectiveness on net investment hedges				$ 0
Cross-currency interest rate swaps | Net Investment Hedging
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, aggregate gross notional amount | €						615
Cross-currency interest rate swaps | Cash Flow Hedging
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, aggregate gross notional amount | €						€ 280

XML

Financial Instruments and Fair Value Measures - Summary of Financial Assets and Liabilities Accounted for at Fair Value on Recurring Basis (Details) € in Millions, $ in Millions	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Dec. 31, 2022 USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	$ 2,884		$ 2,621
Designated as hedging | Interest rate swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts | €		€ 200
Fair value, assets	1
Undesignated as hedging | Interest rate swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts | €		€ 830
Fair value measurements recurring | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	2,884		2,621
Fair value, assets	155		176
Fair value, liabilities	8		8
Fair value measurements recurring | Level 2 | Designated as hedging
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	1,664		1,280
Fair value, assets	87		96
Fair value, liabilities	6		6
Fair value measurements recurring | Level 2 | Designated as hedging | Forward currency exchange contracts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	449		565
Fair value, assets	15		22
Fair value, liabilities	6		6
Fair value measurements recurring | Level 2 | Designated as hedging | Cross-currency interest rate swaps
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	1,015		715
Fair value, assets	71		74
Fair value, liabilities	0		0
Fair value measurements recurring | Level 2 | Designated as hedging | Interest rate swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	200		0
Fair value, assets	1		0
Fair value, liabilities	0		0
Fair value measurements recurring | Level 2 | Undesignated as hedging
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	1,220		1,341
Fair value, assets	68		80
Fair value, liabilities	2		2
Fair value measurements recurring | Level 2 | Undesignated as hedging | Forward currency exchange contracts
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	341		317
Fair value, assets	3		4
Fair value, liabilities	2		2
Fair value measurements recurring | Level 2 | Undesignated as hedging | Interest rate swap
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Notional Amounts	879		1,024
Fair value, assets	65		76
Fair value, liabilities	$ 0		$ 0

XML

Financial Instruments and Fair Value Measures - Summary of Financial Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Carrying Value
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Term Loan Facilities	$ 1,629	$ 1,156
Level 2 | Fair Value
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Term Loan Facilities	$ 1,671	$ 1,151

XML

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ (623)	$ (80)	$ (116)	$ (231)	$ (357)	$ (468)	$ (116)	$ (468)
Other comprehensive income before reclassifications							43	143
Amounts reclassified from accumulated other comprehensive income							(20)	(17)
Total other comprehensive income, net of tax	32	(3)	(6)	64	39	23	23	126
Ending balance	(692)	(623)	(80)	(102)	(231)	(357)	(692)	(102)
Foreign Exchange Translation Adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(44)			(43)	(44)	(43)
Other comprehensive income before reclassifications							8	13
Amounts reclassified from accumulated other comprehensive income							0	0
Total other comprehensive income, net of tax							8	13
Ending balance	(36)			(30)			(36)	(30)
Changes in Fair Value of Effective Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			13			7	13	7
Other comprehensive income before reclassifications							17	43
Amounts reclassified from accumulated other comprehensive income							(20)	(17)
Total other comprehensive income, net of tax							(3)	26
Ending balance	10			33			10	33
Changes in Fair Value of Net Investment Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			85			41	85	41
Other comprehensive income before reclassifications							18	87
Amounts reclassified from accumulated other comprehensive income							0	0
Total other comprehensive income, net of tax							18	87
Ending balance	103			128			103	128
Pension Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(18)			(9)	(18)	(9)
Other comprehensive income before reclassifications							0	0
Amounts reclassified from accumulated other comprehensive income							0	0
Total other comprehensive income, net of tax							0	0
Ending balance	(18)			(9)			(18)	(9)
Total Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	27	30	36	58	19	(4)	36	(4)
Total other comprehensive income, net of tax	32	(3)	(6)	64	39	23
Ending balance	$ 59	$ 27	$ 30	$ 122	$ 58	$ 19	$ 59	$ 122

XML

Earnings Per Share - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Basic earnings per share:
Net income	$ 57	$ 71	$ 81	$ 105	$ 85	$ 88	$ 209	$ 278
Less: preferred stock dividend	0			(40)			(80)	(117)
Less: preferred stock deemed dividends	0			0			(232)	0
Net income (loss) available for distribution	57			65			(103)	161
Less: earnings allocated to participating securities	0			(51)			0	(127)
Net (loss) income available to common shareholders	$ 57			$ 14			$ (103)	$ 34
Weighted average common shares outstanding - Basic (in shares)	250,888,716			64,820,887			141,745,701	64,834,298
EPS – Basic (in USD per share)	$ 0.23			$ 0.21			$ (0.73)	$ 0.52
Diluted earnings per share:
Weighted average common shares outstanding - Basic (in shares)	250,888,716			64,820,887			141,745,701	64,834,298
Dilutive effect of unvested RSUs and other contingently issuable shares (in shares)	1,493,003			429,400			0	283,723
Weighted average common shares outstanding - Diluted (in shares)	252,381,719			65,250,287			141,745,701	65,118,021
EPS – Diluted (in USD per share)	$ 0.23			$ 0.21			$ (0.73)	$ 0.52

XML

Earnings Per Share - Additional Information (Details)	9 Months Ended
	Sep. 30, 2023 shares
Earnings Per Share [Abstract]
Antidilutive shares excluded from computation of diluted EPS (in shares)	1,349,442

XML

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Related Party Transactions [Abstract]
Payments under agreements with Honeywell	$ 0	$ 2	$ 2	$ 6

XML

Related Party Transactions - Narrative (Details) - USD ($) $ in Millions			9 Months Ended
	Jun. 06, 2023	Apr. 12, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Operating lease, liabilities			$ 41
Payments of Additional Amounts for conversion of Series A Preferred Stock	$ 25		$ 25	$ 0
Series A Cumulative Convertible Preferred Stock
Related Party Transaction [Line Items]
Stock repurchase program, authorized amount		$ 570
Conversion of stock, shares converted (in shares)	175,337,712	175,337,712
Common Stock
Related Party Transaction [Line Items]
Issuance of common stock for preference dividends (in shares)	25,577,517	25,577,517
Conversion of stock, shares issued (in shares)	175,337,712
Related Party
Related Party Transaction [Line Items]
Other liabilities					$ 10
Operating lease, liabilities					$ 7
Related Party | Centerbridge Partners, L.P. and Oaktree Capital Management, L.P.
Related Party Transaction [Line Items]
Payments of Additional Amounts for conversion of Series A Preferred Stock		$ 9
Related Party | Honeywell International Inc
Related Party Transaction [Line Items]
Payments of Additional Amounts for conversion of Series A Preferred Stock		1
Related Party | Sessa Capital and its affiliates
Related Party Transaction [Line Items]
Payments of Additional Amounts for conversion of Series A Preferred Stock		$ 2
Related Party | Series A Cumulative Convertible Preferred Stock | Centerbridge Partners, L.P. and Oaktree Capital Management, L.P.
Related Party Transaction [Line Items]
Conversion of stock, shares converted (in shares)		65,334,277
Related Party | Series A Cumulative Convertible Preferred Stock | Honeywell International Inc
Related Party Transaction [Line Items]
Conversion of stock, shares converted (in shares)		4,196,330
Related Party | Series A Cumulative Convertible Preferred Stock | Additional amounts and accumulated dividends
Related Party Transaction [Line Items]
Aggregate accumulated dividend		$ 10
Preferred stock dividends (in shares)		7,276,036
Related Party | Common Stock | Centerbridge Partners, L.P. and Oaktree Capital Management, L.P.
Related Party Transaction [Line Items]
Issuance of common stock for preference dividends (in shares)		6,819,540
Related Party | Common Stock | Honeywell International Inc
Related Party Transaction [Line Items]
Issuance of common stock for preference dividends (in shares)		438,009
Related Party | Common Stock | Sessa Capital and its affiliates
Related Party Transaction [Line Items]
Issuance of common stock for preference dividends (in shares)		1,731,900
Conversion of stock, shares issued (in shares)		16,592,384

XML

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Mar. 31, 2022	Sep. 30, 2023
Brazilian Tax Authorities
Loss Contingencies [Line Items]
Estimated amount of contingency including penalties and interest		$ 37
Securities Litigation
Loss Contingencies [Line Items]
Period to file a third complaint	30 days

XML

Commitments and Contingencies - Summary Information Concerning our Recorded Obligations for Product Warranties and Product Performance Guarantees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of year	$ 27	$ 30	$ 28	$ 32
Accruals for warranties/guarantees issued during the year	2	3	8	10
Settlement of warranty/guarantee claims	(2)	(2)	(9)	(10)
Foreign currency translation	(1)	(2)	(1)	(3)
Balance at end of year	$ 26	$ 29	$ 26	$ 29

XML

Pension Benefits - Additional Information (Details) - Pension benefits - Foreign Plan $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Expected pension contribution in the next fiscal year	$ 7
Pension contribution	$ 6

XML

Pension Benefits - Summary of Net Periodic Benefit Cost (Details) - Pension benefits - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
United States
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0	$ 0	$ 0	$ 1
Interest cost	2	1	6	4
Expected return on plan assets	(2)	(2)	(6)	(6)
Amortization of prior service (credit)	0	0	0	0
Net periodic (income) benefit costs	0	(1)	0	(1)
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	2	4	5
Interest cost	1	0	4	1
Expected return on plan assets	(2)	(2)	(6)	(5)
Amortization of prior service (credit)	0	0	(1)	0
Net periodic (income) benefit costs	$ 0	$ 0	$ 1	$ 1